EurekaMag Full Text Articles Chapter 8,220

Saland, L.C.; Carr, J.A.; Samora, A.; Tejeda, D. 1992: Benzodiazepine suppression of corticotropin releasing factor (CRF)-induced beta-endorphin release from rat neurointermediate pituitary. Peptides (Tarrytown) 13(5): 913-917

Klein, R.L.; Whiting, P.J.; Harris, R.A. 1994: Benzodiazepine treatment causes uncoupling of recombinant GABAA receptors expressed in stably transfected cells. Journal of Neurochemistry 63(6): 2349-2352

Martínez-Cano, H.; Vela-Bueno, A.; De Iceta, M.; Pomalima, R.; Martínez-Gras, I.; Sobrino, M.P. 1996: Benzodiazepine types in high versus therapeutic dose dependence. Addiction 91(8): 1179-1186

Verhaeghe, W.; Mets, T.; Corne, L. 1996: Benzodiazepine use among elderly patients presenting at the emergency room. Archives of Gerontology and Geriatrics 22(1): 55-62

Darke, S.G.; Ross, J.E.; Hall, W.D. 1995: Benzodiazepine use among injecting heroin users. Medical Journal of Australia 162(12): 645-647

Darke, S.; Hall, W.; Ross, M.; Wodak, A. 1992: Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug and Alcohol Dependence 31(1): 31-36

Ross, H.E. 1993: Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 88(2): 209-218

Hemmelgarn, B.; Suissa, S.; Huang, A.; Boivin, J.F.; Pinard, G. 1997: Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278(1): 27-31

Busto, U.E.; Ruiz, I.; Busto, M.; Gacitúa, A. 1996: Benzodiazepine use in Chile: impact of availability on use, abuse, and dependence. Journal of Clinical Psychopharmacology 16(5): 363-372

Mueller, T.I.; Goldenberg, I.M.; Gordon, A.L.; Keller, M.B.; Warshaw, M.G. 1996: Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. Journal of Clinical Psychiatry 57(2): 83-89

Mayer-Oakes, S.A.; Kelman, G.; Beers, M.H.; De Jong, F.; Matthias, R.; Atchison, K.A.; Lubben, J.E.; Schweitzer, S.O. 1993: Benzodiazepine use in older, community-dwelling southern Californians: prevalence and clinical correlates. Annals of PharmacoTherapy 27(4): 416-421

Kaendler, S.H.; Volk, S.; Pflug, B. 1996: Benzodiazepine withdrawal with carbamazepine. Der Nervenarzt 67(5): 381-386

Petry, N.M. 1997: Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Experimental and Clinical Psychopharmacology 5(3): 183-194

Prevett, M.C.; Lammertsma, A.A.; Brooks, D.J.; Cunningham, V.J.; Fish, D.R.; Duncan, J.S. 1995: Benzodiazepine-GABAA receptor binding during absence seizures. Epilepsia 36(6): 592-599

Harris, J.A.; Westbrook, R.F. 1998: Benzodiazepine-induced amnesia in rats: reinstatement of conditioned performance by noxious stimulation on test. Behavioral Neuroscience 112(1): 183-192

Crocker, C.E.; Niles, L.P. 1996: Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth. Anticancer Research 16(3a): 1259-1263

Balleine, B.; Ball, J.; Dickinson, A. 1994: Benzodiazepine-induced outcome revaluation and the motivational control of instrumental action in rats. Behavioral Neuroscience 108(3): 573-589

Zeneroli, M.L.; Venturini, I.; Corsi, L.; Avallone, R.; Farina, F.; Ardizzone, G.; Centanaro, M.; Arrigo, A.; Schreier, P.; Kleinschnitz, M.; Baraldi, M. 1998: Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failure. Scandinavian Journal of Gastroenterology 33(3): 310-313

Fryer, R.I.; Wang, C.G.; Chia, N.C.; Basile, A.S.; Gu, Z.Q.; Skolnick, P. 1995: Benzodiazepine-receptor (BZR) ligands: The conformational fit of agonist beta-carbolines to an imidazobenzodiazepine template. Medicinal Chemistry Research 5(4): 296-307

Rush, C.R.; Armstrong, D.L.; Ali, J.A.; Pazzaglia, P.J. 1998: Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. Journal of Clinical Psychopharmacology 18(2): 154-165

Bonnafous, C.; Lefevre, P.; Bueno, L. 1995: Benzodiazepine-withdrawal-induced gastric emptying disturbances in rats: evidence for serotonin receptor involvement. Journal of Pharmacology and Experimental Therapeutics 273(3): 995-1000

Morand, N.; Veuillet, E.; Gagnieu, M.C.; Lemoine, P.; Collet, L. 1998: Benzodiazepines alter cochleo-cochlear loop in humans. Hearing Research 121(1-2): 71-76

Delini-Stula, A.; Berdah-Tordjman, D. 1995: Benzodiazepines and GABA hypothesis of schizophrenia. Journal of Psychopharmacology 9(1): 57-63

Fava, G.A.; Grandi, S.; Belluardo, P.; Savron, G.; Raffi, A.R.; Conti, S.; Saviotti, F.M. 1994: Benzodiazepines and anxiety sensitivity in panic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 18(7): 1163-1168

Spiegel, D.A.; Bruce, T.J. 1997: Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. American Journal of Psychiatry 154(6): 773-781

Barnas, C.; Rossmann, M.; Roessler, H.; Riemer, Y.; Fleischhacker, W.W. 1992: Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. Clinical Neuropharmacology 15 Suppl 1 Pt A: 110a-111a

Gray, R.W.; Cooper, S.J. 1995: Benzodiazepines and palatability: taste reactivity in normal ingestion. Physiology and Behavior 58(5): 853-859

Mccauley, L.D.; Park, C.H.; Lan, N.C.; Tomich, J.M.; Shively, J.E.; Gee, K.W. 1995: Benzodiazepines and peptides stimulate pregnenolone synthesis in brain mitochondria. European Journal of Pharmacology 276(1-2): 145-153

Herings, R.M.; Stricker, B.H.; de Boer, A.; Bakker, A.; Sturmans, F. 1995: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Archives of Internal Medicine 155(16): 1801-1807

Weiss, M.; Mirow, N.; Birkhahn, A.; Schneider, M.; Wernet, P. 1993: Benzodiazepines and their solvents influence neutrophil granulocyte function. British Journal of Anaesthesia 70(3): 317-321

Irwin, M.; Hauger, R.L.; Britton, K. 1993: Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. Brain Research 631(1): 114-118

Petty, F.; Trivedi, M.H.; Fulton, M.; Rush, A.J. 1995: Benzodiazepines as antidepressants: Does GABA play a role in depression?. Biological Psychiatry 38(9): 578-591

Korbonits, M.; Trainer, P.J.; Edwards, R.; Besser, G.M.; Grossman, A.B. 1995: Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome. Clinical Endocrinology 43(1): 29-35

Hong, S.J.; Damron, D.S.; Murray, P.A. 1998: Benzodiazepines differentially inhibit phenylephrine-induced calcium oscillations in pulmonary artery smooth muscle cells. Anesthesiology 88(3): 792-799

Söderpalm, A.H.; Hansen, S. 1998: Benzodiazepines enhance the consumption and palatability of alcohol in the rat. Psychopharmacology 137(3): 215-222

Peppers, M.P. 1996: Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease. Pharmacotherapy 16(1): 49-57

Birkenhäger, T.K.; Moleman, P.; Nolen, W.A. 1995: Benzodiazepines for depression? A review of the literature. International Clinical Psychopharmacology 10(3): 181-195

Biberdorf, D.J.; Steens, R.; Millar, T.W.; Kryger, M.H. 1993: Benzodiazepines in congestive heart failure: effects of temazepam on arousability and Cheyne-Stokes respiration. Sleep 16(6): 529-538

Boixet, M.; Batlle, E.; Bolibar, I. 1996: Benzodiazepines in primary health care: A survey of general practitioners prescribing patterns. Addiction 91(4): 549-556

Ungvari, G.S.; Leung, C.M.; Wong, M.K.; Lau, J. 1994: Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scandinavica 89(4): 285-288

Rattray, M.; Singhvi, S.; Wu, P.Y.; Andrews, N.; File, S.E. 1993: Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain. European Journal of Pharmacology 245(2): 193-196

Meissl, H.; Yáñez, J.; Ekström, P.; Grossmann, E. 1994: Benzodiazepines influence melatonin secretion of the pineal organ of the trout in vitro. Journal of Pineal Research 17(2): 69-78

Mantel, P.; Van Hamme, J.; Piek, T.; Leeuwin, R.S. 1998: Benzodiazepines modify evoked action potentials of the rat sciatic nerve in vitro. Neuroscience Research Communications 22(3): 163-170

Rovira, C.; Ben-Ari, Y. 1994: Benzodiazepines modulate calcium spikes in young and adult hippocampal cells. Neuroreport 5(16): 2125-2129

Gandolfo, G.; Scherschlicht, R.; Gottesmann, C. 1994: Benzodiazepines promote the intermediate stage at the expense of paradoxical sleep in the rat. Pharmacology Biochemistry and Behavior 49(4): 921-927

Van der Meersch-Mougeot, V.; da Rocha, M.; Monier, C.; Diquet, B.; Puech, A.J.; Thiébot, M.H. 1993: Benzodiazepines reverse the anti-immobility effect of antidepressants in the forced swimming test in mice. Neuropharmacology 32(5): 439-446

Diaz Maroto Munoz, S. 1998: Benzodiazepines, criteria of use as hypnotic and anxiolytic agents. Farmacia Clinica 15(2): 96-108

Lechin, F.; van der Dijs, B.; Benaim, M. 1996: Benzodiazepines: tolerability in elderly patients. PsychoTherapy and Psychosomatics 65(4): 171-182

Fastbom, J.; Forsell, Y.; Winblad, B. 1998: Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Disease and Associated Disorders 12(1): 14-17

Middlemiss, D.; Watson, S.P.; Ross, B.C.; Dowle, M.D.; Scopes, D.I.C.; Montana, J.G.; Shah, P.; Hirst, G.C.; Panchal, T.A. 1993: Benzofuran based angiotensin II antagonists related to GR117289: Enhancement of potency in vitro and oral activity. Bioorganic and Medicinal Chemistry Letters 3(4): 589-594

Dowle, M.D.; Judd, D.B.; Middlemiss, D.; Scopes, D.I.C.; Ross, B.C.; Pass, M.; Tranquillini, E.; Jack, T.I.; Hobson, J.E. 1993: Benzofuran based angiotensin II antagonists related to GR117289: Part III: GR138950, a triflamide with high oral bioavailability. Bioorganic and Medicinal Chemistry Letters 3(10): 2047-2050

Judd, D.B.; Cardwell, K.S.; Panchal, T.A.; Jack, T.I.; Pass, M.; Hubbard, T.; Dean, A.W.; Butt, A.U.; Hobson, J.E. 1994: Benzofuran based non-peptide antagonists of angiotensin II related to GR117289: Part IV. Imidazopyridinylbenzofurans. Bioorganic and Medicinal Chemistry Letters 4(5): 725-728

Kaltenbronn, J.S.; Quini, J.I.; Reisdorph, B.R.; Klutchko, S.; Reynolds, E.E.; Welch, K.M.; Flynn, M.A.; Doherty, A.M. 1997: Benzofuran derivatives as ET-A-selective, non-peptide endothelin antagonists. European Journal of Medicinal Chemistry 32(5): 425-431

Gasco, A.M.; Ermondi, G.; Fruttero, R.; Gasco, A. 1996: Benzofurazanyl- and benzofuroxanyl-1,4-dihydropyridines: Synthesis, structure and calcium entry blocker activity. European Journal of Medicinal Chemistry 31(1): 3-10

Semenov, F.V.; Gorbonosov, I.B.; Evglevskii, A.A.; Volik, A.K. 1996: Benzofurocaine stimulation of regeneration in surgical treatment of chronic otitis media purulenta. Vestnik Otorinolaringologii 1996(2): 45-48

Ksander, G.M.; Savage, P.; Trapani, A.J.; Balwierczak, J.L.; Jeng, A.Y. 1998: Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme. Journal of Cardiovascular Pharmacology 31(Suppl 1): S71-S73

Sieber, R.; Buetikofer, U.; Bosset, J.O. 1995: Benzoic Acid as a Natural Compound in Cultured Dairy Products and Cheese. International Dairy Journal 5(3): 227-246

León, J.; Shulaev, V.; Yalpani, N.; Lawton, M.A.; Raskin, I. 1995: Benzoic acid 2-hydroxylase, a soluble oxygenase from tobacco, catalyzes salicylic acid biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 92(22): 10413-10417

Profozic, V.; Babic, D.; Renar, I.; Rupprecht, E.; Skrabalo, Z.; Metelko, Z. 1996: Benzoic acid derivative hypoglycemic activity and pharmacokinetics in non-insulin dependent diabetic patients. Diabetologia Croatica 25(3): 109-116

Ali, Z.; Ahmad, V.U.; Zahid, M.; Tareen, R.B. 1998: Benzoic acid derivatives from Stocksia brahuica. Phytochemistry (oxford). 48(7): 1271-1273,.

Poon, K.; Pang, K.S. 1995: Benzoic acid glycine conjugation in the isolated perfused rat kidney. Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(2): 255-260

Luo, M.; Jedrzejas, M.J.; Singh, S.; White, C.L.; Brouillette, W.J.; Air, G.M.; Laver, W.G. 1995: Benzoic acid inhibitors of influenza virus neuraminidase. Acta Crystallographica. Section D Biological Crystallography 51(Part 4): 504-510

De-Vita, R., J.; Schoen, W., R.; Fisher, M., H.; Frontier, A., J.; Pisano, J., M.; Wyvratt, M., J.,. Jr.;; Cheng, K.; Chan, W., W.S.; Butler, B., S.; Hickey, G., J.; Jacks, T., M.; Smith, R., G. 1994: Benzolactam growth hormone secretagogues: Carboxamides as replacements for the 2'-tetrazole moiety of L-692,429. Bioorganic and Medicinal Chemistry Letters 4(18): 2249-2254

Devita, R., J.; Schoen, W., R.; Ok, D.; Barash, L.; Brown, J., E.; Fisher, M., H.; Hodges, P.; Wyvratt, M., J.,. Jr.;; Cheng, K. 1994: Benzolactam growth hormone secretagogues: Replacements for the 2'-tetrazole moiety of L-692,429. Bioorganic and Medicinal Chemistry Letters 4(15): 1807-1812

Bock, M.G.; Dipardo, R.M.; Veber, D.F.; Chang, R.S.L.; Lotti, V.J.; Freedman, S.B.; Freidinger, R.M. 1993: Benzolactams as non-peptide cholecystokinin receptor ligands. Bioorganic and Medicinal Chemistry Letters 3(5): 870-874

Gottfried, J.A.; Chesler, M. 1995: Benzolamide inhibits low-threshold calcium currents in hippocampal pyramidal neurons. Journal of Neurophysiology 74(6): 2774-2777

Sun, H.H.; Barrow, C.J.; Cooper, R. 1995: Benzomalvin D, a new 1,4-benzodiazepine atropisomer. Journal Of Natural Products (lloydia). 58(10): 1575-1580

Sun, H.H.; Barrow, C.J.; Sedlock, D.M.; Gillum, A.M.; Cooper, R. 1994: Benzomalvins, new substance P inhibitors from a Penicillium sp. Journal of Antibiotics 47(5): 515-522

Lipkowski, A., W.; Misicka, A.; Porreca, F.; Davis, P.; Yamamura, H., I.; Stropova, D.; Hruby, V., J. 1995: Benzomorphan alkaloids: Natural peptidomimetics of opioid peptide pharmacophores. Letters in Peptide Science 2(3-4): 177-181

Wuensch, B.; Bauschke, G. 1993: Benzomorphan analogues with doxpicomine substructure: Synthesis and psychopharmacological investigation of 5-aminomethyl and 5-(alpha-aminobenzyl) substituted 2,6-epoxy-3-benzoxocines. Archiv der Pharmazie (Weinheim) 326(3): 171-180

Doona, M.; Walsh, D. 1998: Benzonatate for opioid-resistant cough in advanced cancer. Palliative Medicine 12(1): 55-58

Gelsema, W.J.; van den Brink, O.F.; van den Bosch, H. 1996: Benzoolysis of diacylglycerophosphocholines: dephosphorylation and sequential formation of isomeric reaction products. Journal of Lipid Research 37(6): 1224-1233

Wyatt, P.G.; Bethell, R.C.; Cammack, N.; Charon, D.; Dodic, N.; Dumaitre, B.; Evans, D.N.; Green, D.V.; Hopewell, P.L.; Humber, D.C. 1995: Benzophenone derivatives: A novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Journal of Medicinal Chemistry 38(10): 1657-1665

Dormán, G.; Prestwich, G.D. 1994: Benzophenone photophores in biochemistry. Biochemistry 33(19): 5661-5673

Prestwich, G.D.; Dormán, G.; Elliott, J.T.; Marecak, D.M.; Chaudhary, A. 1997: Benzophenone photoprobes for phosphoinositides, peptides and drugs. Photochemistry and Photobiology 65(2): 222-234

Murgida, D., H.; Aramendia, P., F.; Erra-Balsells, R. 1998: Benzophenone-photosensitized reactions of xanthinic compounds. A mechanistic study. Photochemistry and Photobiology 67(5): 487-494

Markovic, D.Z.; Patterson, L.K. 1993: Benzophenone-sensitized lipid peroxidation in linoleate micelles. Photochemistry and Photobiology 58(3): 329-334

Krainev, A.K.; Viner, R.I.; Bigelow, D.J. 1997: Benzophenone-sensitized photooxidation of sarcoplasmic reticulum membranes: site-specific modification of the Ca(2+)-ATPase. Free Radical Biology and Medicine 23(7): 1009-1020

Olivares, E.M.; Gonzalez, J.G.; Monache, F.D. 1994: Benzophenones from Clusia ellipticifolia. Phytochemistry (oxford). 36(2): 473-475

Cincotta, L.; Szeto, D.; Lampros, E.; Hasan, T.; Cincotta, A.H. 1996: Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochemistry and Photobiology 63(2): 229-237

Allison, B.A.; Hamilton, J. 1996: Benzoporphyrin derivative decreases the binding of low density lipoprotein to the glycosaminoglycan chondroitin-6-sulfate in vitro. Atherosclerosis 125(2): 153-160

Wyss, P.; Tadir, Y.; Tromberg, B.J.; Liaw, L.; Krasieva, T.; Berns, M.W. 1994: Benzoporphyrin derivative: a potent photosensitizer for photodynamic destruction of rabbit endometrium. Obstetrics and Gynecology 84(3): 409-414

Schmidt-Erfurth, U.; Flotte, T.J.; Gragoudas, E.S.; Schomacker, K.; Birngruber, R.; Hasan, T. 1996: Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors. Experimental Eye Research 62(1): 1-10

Bhat, S.; Otsuka, T.; Srinivasan, A. 1994: Benzopurpurin and related compounds inhibit the binding of gp120 to galactosyl ceramide/sulfatide and infection of human immunodeficiency virus. Dna and Cell Biology 13(2): 211-216

Piacente, Sonia; Hernandez, Nora Herrera; De Simone, Francesco; De Ugaz, Olga Lock; Pizza, Cosimo 1997: Benzopyran derivatives from Werneria nubigena. Phytochemistry (oxford). 46(4): 795-797,.

Van, N.H.; Kamperdick, C.; Van Sung, T.; Adam, G. 1998: Benzopyran dimers from Melicope ptelefolia. Phytochemistry (oxford). 48(6): 1055-1057

Grese, T., A.; Sluka, J., P.; Bryant, H., U.; Cole, H., W.; Kim, J., R.; Maggee, D., E.; Rowley, E., R.; Sato, M. 1996: Benzopyran selective estrogen receptor modulators (SERMs): Pharmacological effects and structural correlation with raloxifene. Bioorganic and Medicinal Chemistry Letters 6(7): 903-908

Yoo, S.E.; Kim, S.J.; Shin, H.S.; Hong, K.W. 1993: Benzopyran sulfoxide derivatives as new potassium channel activator. Bioorganic and Medicinal Chemistry Letters 3(4): 553-554

Ghosh, C.-Kanta; Sahana, S.; Patra, A. 1993: Benzopyrans: Part 30. Synthesis of substituted xanthones from 3-acyl-2-methylbenzopyran-4-ones. Tetrahedron 49(19): 4127-4134

Pendergast, W.; Dickerson, S.H.; Johnson, J.V.; Dev, I.K.; Ferone, R.; Duch, D.S.; Smith, G.K. 1993: Benzoquinazoline inhibitors of thymidylate synthase: Enzyme inhibitory activity and cytotoxicity of some sulfonamidobenzoylglutamate and related derivatives. Journal of Medicinal Chemistry 36(22): 3464-3471

Palmeira, C.M.; Wallace, K.B. 1997: Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicology and Applied Pharmacology 143(2): 338-347

Surya, A.; Murthy, N.; Anita 1993: Benzoquinone-mediated glucose/glucose oxidase reaction at pyrolytic graphite electrode. Electroanalysis 5(3): 265-268

Niwa, M.; Nakamura, N.; Kitajima, K.; Ueda, M.; Tsutsumishita, Y.; Futaki, S.; Takaishi, Y. 1997: Benzoquinones inhibit the expression of inducible nitric oxide synthase gene. Biochemical and Biophysical Research Communications 239(2): 367-371

Huang, P.L.; Gan, K.H.; Wu, R.R.; Lin, C.N. 1997: Benzoquinones, a homoisoflavanone and other constitutents from Polygonatum alte-lobatum. Phytochemistry 44(7): 1369-1373

Galet, V.; Bernier, J.L.; Hénichart, J.P.; Lesieur, D.; Abadie, C.; Rochette, L.; Lindenbaum, A.; Chalas, J.; Renaud de la Faverie, J.F.; Pfeiffer, B. 1994: Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity. Journal of Medicinal Chemistry 37(18): 2903-2911

Yamada, K.A.; Tang, C.M. 1993: Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 13(9): 3904-3915

Martinez, Ana; Esteban, Ana I.; De Clercq, Erik 1997: Benzothiadiazine dioxide acyclonucleosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infections. Bioorganic and Medicinal Chemistry Letters 7(8): 1031-1032

Brauns, T.; Cai, Z.W.; Kimball, S.D.; Kang, K.C.; Haugland, R.P.; Berger, W.; Berjukov, S.; Hering, S.; Glossmann, H.; Striessnig, J. 1995: Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry 34(10): 3461-3469

Aotsuka, T.; Abe, N.; Fukushima, K.; Ashizawa, N.; Yoshida, M. 1997: Benzothiazol-2-ylcarboxylic acids with diverse spacers: A novel class of potent, orally active aldose reductase inhibitors. Bioorganic and Medicinal Chemistry Letters 7(13): 1677-1682

Waddell, S., T.; Ratcliffe, R., W.; Szumiloski, S., P.; Wildonger, K., J.; Wilkening, R., R.; Blizzard, T., A.; Huber, J.; Kohler, J.; Dorso, K.; St-Rose, E.; Sundelof, J., G.; Hammond, G., G. 1995: Benzothiazolylthio carbapenems: Potent anti-MRSA agents. Bioorganic and Medicinal Chemistry Letters 5(13): 1427-1432

Katritzky, A.R.; Nichols, D.A.; Qi, M. 1998: Benzotriazole mediated syntheses of alpha-fluoro-beta-amino esters. Tetrahedron Letters 39(39): 7063-7066

Kuroita, T.; Marubayashi, N.; Sano, M.; Kanzaki, K.; Inaba, K.; Kawakita, T. 1996: Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists. Chemical and Pharmaceutical Bulletin 44(11): 2051-2060

Lazer, E.S.; Miao, C.K.; Wong, H.C.; Sorcek, R.; Spero, D.M.; Gilman, A.; Pal, K.; Behnke, M.; Graham, A.G.; Watrous, J.M. 1994: Benzoxazolamines and benzothiazolamines: Potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action. Journal of Medicinal Chemistry 37(7): 913-923

Sato, Y.; Yamada, M.; Yoshida, S.; Soneda, T.; Ishikawa, M.; Nizato, T.; Suzuki, K.; Konno, F. 1998: Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut. Journal of Medicinal Chemistry 41(16): 3015-3021

Satoh, Y.; Libby, A.H.; Powers, C.; Kowalski, T.J.; White, D.H.; Kimble, E.F. 1994: Benzoxepin and benzothiepin derivatives as potent, orally active inhibitors of 5-lipoxygenase. Bioorganic and Medicinal Chemistry Letters 4(4): 549-552

Verhegge, P.; Pollet, A.; Vandenbossche, A. 1994: Benzoxonium chloride as an alternative to antibiotics in acute non-specific sore throat: Single-blind, comparative, randomised clinical trial, versus roxithromycin. Acta Therapeutica 20(3-4): 151-164

Weng, Y.M.; Chen, M.J.; Chen, W. 1997: Benzoyl chloride modified ionomer films as antimicrobial food packaging materials. International Journal of Food Science & Technology 32(3): 229-234

Kennedy, S.H.; Manevich, Y.; Biaglow, J. 1995: Benzoyl peroxide acts as a promoter of radiation induced malignant transformation in vitro. Biochemical and Biophysical Research Communications 212(1): 118-125

Babich, H.; Zuckerbraun, H.L.; Wurzburger, B.J.; Rubin, Y.L.; Borenfreund, E.; Blau, L. 1996: Benzoyl peroxide cytotoxicity evaluated in vitro with the human keratinocyte cell line, RHEK-1. Toxicology 106(1-3): 187-196

Ibbotson, S.H.; Lambert, C.R.; Moran, M.N.; Lynch, M.C.; Kochevar, I.E. 1998: Benzoyl peroxide increases UVA-induced plasma membrane damage and lipid oxidation in murine leukemia L1210 cells. Journal of Investigative Dermatology 110(1): 79-83

Singh, N.; Aggarwal, S. 1996: Benzoyl peroxide modulates gene expression by epigenetic mechanism in mouse epidermal JB6 cells. Indian Journal of Experimental Biology 34(7): 647-651

Chellquist, E.M.; Gorman, W.G. 1992: Benzoyl peroxide solubility and stability in hydric solvents. Pharmaceutical Research 9(10): 1341-1346

Hazlewood, C.; Davies, M.J. 1996: Benzoyl peroxide-induced damage to DNA and its components: direct evidence for the generation of base adducts, sugar radicals, and strand breaks. Archives of Biochemistry and Biophysics 332(1): 79-91

Kraus, A.L.; Munro, I.C.; Orr, J.C.; Binder, R.L.; LeBoeuf, R.A.; Williams, G.M. 1995: Benzoyl peroxide: an integrated human safety assessment for carcinogenicity. Regulatory Toxicology and Pharmacology: Rtp 21(1): 87-107

Boll, M.; Albracht, S.S.; Fuchs, G. 1997: Benzoyl-CoA reductase (dearomatizing), a key enzyme of anaerobic aromatic metabolism. A study of adenosinetriphosphatase activity, ATP stoichiometry of the reaction and EPR properties of the enzyme. European Journal of Biochemistry 244(3): 840-851

Boll, M.; Fuchs, G. 1995: Benzoyl-coenzyme A reductase (dearomatizing), a key enzyme of anaerobic aromatic metabolism. ATP dependence of the reaction, purification and some properties of the enzyme from Thauera aromatica strain K172. European Journal of Biochemistry 234(3): 921-933

Niemetz, R.; Altenschmidt, U.; Brucker, S.; Fuchs, G. 1995: Benzoyl-coenzyme-A 3-monooxygenase, a flavin-dependent hydroxylase. Purification, some properties and its role in aerobic benzoate oxidation via gentisate in a denitrifying bacterium. European Journal of Biochemistry 227(1-2): 161-168

Gibbons, S.; Gray, A., I.; Waterman, P., G.; Hockless, D., C.R.; Skelton, B., W.; White, A., H. 1995: Benzoylated derivatives of 2-beta-glucopyranosyloxy-2,5-dihydroxybenzyl alcohol from Xylosma flexuosum: Structure and relative configuration of xylosmin. Journal of Natural Products 58(4): 554-559

Oehlke, J.; Brudel, M.; Blasig, I.E. 1994: Benzoylation of sugars, polyols and amino acids in biological fluids for high-performance liquid chromatographic analysis. Journal of Chromatography. B, Biomedical Applications 655(1): 105-111

Demilo, A., B.; Gelman, D., B.; Bordas, B. 1997: Benzoylbiuret insect chitin inhibitors: Structure-activity correlations derived from an in vitro clasper assay and an in vivo mosquito adult emergency assay. Journal of Entomological Science 32(2): 212-228

Ramcharitar, V.; Levine, B.; Smialek, J.E. 1995: Benzoylecgonine and ecgonine methyl ester concentrations in urine specimens. Journal of Forensic Sciences 40(1): 99-101

Gowda, D.C.; Ambekar, S.Y.; Gupta, P.; Lecchi, P.; Pannell, L.K.; Davidson, E.A. 1996: Benzoylecgonine hydrazides: synthesis, coupling to horseradish peroxidase, and characterization of the conjugates. Bioconjugate Chemistry 7(2): 265-270

Marecak, D.M.; Horiuchi, Y.; Arai, H.; Shimonaga, M.; Maki, Y.; Koyama, T.; Ogura, K.; Prestwich, G.D. 1997: Benzoylphenoxy analogs of isoprenoid diphosphates as photoactivatable substrates for bacterial prenyltransferases. Bioorganic and Medicinal Chemistry Letters 7(15): -1978

Mazzanti, R.; Croop, J.M.; Gatmaitan, Z.; Budding, M.; Steiglitz, K.; Arceci, R.; Arias, I.M. 1992: Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells. Oncology Research 4(8-9): 359-365

Rosano, T.G.; Meola, J.M.; Wolf, B.C.; Guisti, L.W.; Jindal, S.P. 1994: Benztropine identification and quantitation in a suicidal overdose. Journal of Analytical Toxicology 18(6): 348-353

Friedman, J.H.; Koller, W.C.; Lannon, M.C.; Busenbark, K.; Swanson-Hyland, E.; Smith, D. 1997: Benztropine versus clozapine for the treatment of tremor in Parkinson's disease. Neurology 48(4): 1077-1081

Sironi, M.; Milanese, C.; Vecchi, A.; Polenzani, L.; Guglielmotti, A.; Coletta, I.; Landolfi, C.; Soldo, L.; Mantovani, A.; Pinza, M. 1997: Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. International Journal of Clinical and Laboratory Research 27(2): 118-122

Grzeszczyk, B.; Zamojski, A. 1994: Benzyl 7-O-allyl-2,3-O-isopropylidene-4-O-p-methoxybenzyl-L-glycero-alpha-D-manno-heptopyranoside, a versatile LD-man Hepp derivative. Carbohydrate Research 262(1): 49-57

Giocondi, M.C.; Mamdouh, Z.; Le Grimellec, C. 1995: Benzyl alcohol differently affects fluid phase endocytosis and exocytosis in renal epithelial cells. Biochimica Et Biophysica Acta 1234(2): 197-202

Goetghebeur, M.; Brun, S.; Galzy, P.; Nicolas, M. 1993: Benzyl alcohol oxidase and laccase synthesis in Botrytis cinerea. Bioscience Biotechnology and Biochemistry 57(8): 1380-1381

Muriana, F.J.; Relimpio, A.M. 1993: Benzyl viologen inactivation of rat liver glutamine synthetase. Journal of Biochemistry 113(6): 738-741

Delannoy, P.; Kim, I.; Emery, N.; De Bolos, C.; Verbert, A.; Degand, P.; Huet, G. 1996: Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconjugate Journal 13(5): 717-726

Nakano, T.; Matsui, T.; Ota, T. 1996: Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells. Anticancer Research 16(6b): 3577-3584

Yee, L.K.; Chu, E.; Pan, B.C.; Chu, S.H.; Chen, T.M.; Lipsky, M.H.; Chu, M.Y.; Calabresi, P. 1998: Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines. Pharmacology 56(2): 80-91

Mcartney, S.J.; Tustin, D.S.; Seymour, S.; Cashmore, W.; Looney, N.E. 1995: Benzyladenine and carbaryl effects on fruit thinning and the enhancement of return flowering of three apple cultivars. Journal of Horticultural Science 70(2): 287-296

Van-Staden, J.; Crouch, N.R. 1996: Benzyladenine and derivatives: Their significance and interconversion in plants. Plant Growth Regulation 19(2): 153-175

Yu, M.J.; McCowan, J.R.; Phebus, L.A.; Towner, R.D.; Ho, P.P.; Keith, P.T.; Luttman, C.A.; Saunders, R.D.; Ruterbories, K.J.; Lindstrom, T.D. 1993: Benzylamine antioxidants: Relationship between structure, peroxyl radical scavenging, lipid peroxidation inhibition, and cytoprotection. Journal of Medicinal Chemistry 36(9): 1262-1271

Lee, K.; Jung, W.H.; Park, C.W.; Hong, C.Y.; Kim, I.C.; Kim, S.; Oh, Y.S.; Kwon, O.H.; Lee, S.H.; Park, H.D.; Kim, S.W.; Lee, Y.H.; Yoo, Y.J. 1998: Benzylamine-based selective and orally bioavailable inhibitors of thrombin. Bioorganic and Medicinal Chemistry Letters 8(18): 2563-2568,. 22

Jensen, H.S.; Limberg, G.; Pedersen, C. 1997: Benzylation of aldonolactones with benzyl trichloroacetimidate. Carbohydrate Research 302(1-2): 109-112

Migaud, M.E.; Chee-Sanford, J.C.; Tiedje, J.M.; Frost, J.W. 1996: Benzylfumaric, benzylmaleic, and Z- and E-phenylitaconic acids: synthesis, characterization, and correlation with a metabolite generated by Azoarcus tolulyticus Tol-4 during anaerobic toluene degradation. Applied and Environmental Microbiology 62(3): 974-978

Banik, B., K.; Venkatraman, M.S.; Mukhopadhyay, C.; Becker, F., F. 1998: Benzylic oxidation by sodium bismuthate in acetic acid: A simple method for the synthesis of polycyclic aromatic ketones. Tetrahedron Letters 39(40): 7247-7250

Tanuma, S.; Shiokawa, D.; Tanimoto, Y.; Ikekita, M.; Sakagami, H.; Takeda, M.; Fukuda, S.; Kochi, M. 1993: Benzylideneascorbate induces apoptosis in L929 tumor cells. Biochemical and Biophysical Research Communications 194(1): 29-35

Sakamoto, M.; Nozaka, A.; Shimamoto, M.; Ozaki, H.; Suzuki, Y.; Yoshioka, S.; Nagano, M.; Okamura, K.; Date, T.; Tamura, O. 1994: Benzylidenecyanomethyl-1,3-benzazoles as 1-aza-1,3-butadienes. Chemical and Pharmaceutical Bulletin 42(6): 1367-1369

Law, H.; Dukat, M.; Teitler, M.; Lee, D.K.; Mazzocco, L.; Kamboj, R.; Rampersad, V.; Prisinzano, T.; Glennon, R.A. 1998: Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation. Journal of Medicinal Chemistry 41(13): 2243-2251

Kanyinda, B.; Vanhaelen Fastre, R.; Vanhaelen, M. 1995: Benzylisoquinoline alkaloids from Anisocycla jollyana leaves. Journal Of Natural Products (lloydia). 58(10): 1587-1589

Bandaranayake, W., M.; Wickramasinghe, W., A. 1996: Benzylmercaptan (benzylthiol) and dibenzyldisulphide from the marine sponge Crella spinulata, (Hentschel) (Poecilosclerida: Crellidae). Comparative Biochemistry and Physiology B 113(3): 499-502

Claeson, G.; Philipp, M.; Agner, E.; Scully, M.F.; Metternich, R.; Kakkar, V.V.; DeSoyza, T.; Niu, L.H. 1993: Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 position. Biochemical Journal 290: 309-312

Slee, E.A.; Zhu, H.; Chow, S.C.; MacFarlane, M.; Nicholson, D.W.; Cohen, G.M. 1996: Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochemical Journal 315: 21-24

Kahyaoglu, A.; Haghjoo, K.; Kraicsovits, F.; Jordan, F.; Polgar, L. 1997: Benzyloxycarbonylprolylprolinal, a transition-state analogue for prolyl oligopeptidase, forms a tetrahedral adduct with catalytic serine, not a reactive cysteine. Biochemical Journal 322: 839-843

Zhang, L.; Wang, Y.M.; Chen, B.Y.; Shen, G. 1996: Benzylpenicillin induced specific non-IgE antibody response in mice. Zhongguo Yao Li Xue Bao 17(6): 531-534

Schwender, C.F.; Beers, S.A.; Malloy, E.A.; Cinicola, J.J.; Wustrow, D.J.; Demarest, K.D.; Jordan, J. 1996: Benzylphosphonic acid inhibitors of human prostatic acid phosphatase. Bioorganic and Medicinal Chemistry Letters 6(3): 311-314

Sasaki, K.; Shibata, Y.; Hashimoto, Y.; Iwasaki, S. 1995: Benzylphthalimides and phenethylphthalimides with thalidomide-like activity on the production of tumor necrosis factor alpha. Biological and Pharmaceutical Bulletin 18(9): 1228-1233

Viallon, A.; Page, Y.; Lafond, P.; Guy, C.; Cusey, I.; Tardy, B.; Zeni, F.; Lapierre, B.; Bertrand, J.C. 1994: Bepridil and torsades de pointes: are the precautions of use respected?. Therapie 49(5): 431-434

Johnson, R.M.; Acquaye, C.; Féo, C.; Sarnaik, S. 1994: Bepridil as an antisickling agent: Membrane internalization and cell rigidity. American Journal of Hematology 46(4): 310-318

Lee, Y.S.; Wurster, R.D. 1996: Bepridil enhances in vitro antitumor activity of antiestrogens in human brain tumor cells. Cancer Letters 110(1-2): 243-248

Zusman, R.M.; Higgins, J.; Christensen, D.; Boucher, C.A. 1993: Bepridil improves left ventricular performance in patients with angina pectoris. Journal of Cardiovascular Pharmacology 22(3): 474-480

Nobe, S.; Aomine, M.; Arita, M. 1993: Bepridil prolongs the action potential duration of guinea pig ventricular muscle only at rapid rates of stimulation. General Pharmacology 24(5): 1187-1196

Chen, D.D.; Dai, D.Z.; Chu, Y.X. 1996: Bepridil reducing levothyroxine-induced enhancement of mitochondria Ca2+ Mg(2+)-ATPase activity in rat cerebrum. Zhongguo Yao Li Xue Bao 17(5): 432-434

Chen, D.D.; Chu, Y.X.; Dai, D.Z. 1995: Bepridil reverses cardiac hypertrophy and elevated sarcolemmal Ca-2+, Mg-2+ -ATPase activity induced by L-thyroxine in rats. Zhongguo Yaolixue Yu Dulixue Zazhi 9(3): 228-230

Sobolevsky, A.; Koshelev, S.; Khodorov, B.I. 1997: Bepridil-induced blockade of NMDA channels in rat hippocampal neurones. Neuropharmacology 36(3): 319-324

Aoyama, T.; Kojima, F.; Abe, F.; Muraoka, Y.; Naganawa, H.; Takeuchi, T.; Aoyagi, T. 1993: Bequinostatins A and B new inhibitors of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. Production, isolation, structure determination and biological activities. Journal of Antibiotics 46(6): 914-920

Bailey, M.E.; Brown, R.W.; Mody, D.R.; Cagle, P.; Ramzy, I. 1996: Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1. Acta Cytologica 40(6): 1212-1216

Jimenez, F.J.; Burchette, J.L.; Grichnik, J.M.; Hitchcock, M.G. 1995: Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 8(8): 854-858

Togawa, M.; Haneda, M.; Araki, S.I.; Sugimoto, T.; Isono, M.; Hidaka, H.; Yasuda, H.; Kashiwagi, A.; Kikkawa, R. 1997: Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells. European Journal of Pharmacology 336(2-3): 291-294

Kuo, C.L.; Chou, C.C.; Yung, B.Y. 1995: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Letters 93(2): 193-200

Taylor, C.T.; Baird, A.W. 1995: Berberine inhibition of electrogenic ion transport in rat colon. British Journal of Pharmacology 116(6): 2667-2672

Husain, T.; Datt, B.; Rao, R.R. 1994: Berberis kunawurensis Royle, var. diversifolia (Berberidaceae), a new variety from E. Himalayas, India. Rheedea 4(1): 37-39

Rynearson, E.K. 1995: Bereavement after homicide. A comparison of treatment seekers and refusers. British Journal of Psychiatry: the Journal of Mental Science 166(4): 507-510

Rynearson, E.K.; McCreery, J.M. 1993: Bereavement after homicide: a synergism of trauma and loss. American Journal of Psychiatry 150(2): 258-261

Grimby, A. 1993: Bereavement among elderly people: Grief reactions, post-bereavement hallucinations and quality of life. Acta Psychiatrica Scandinavica 87(1): 72-80

Hollins, S.; Esterhuyzen, A. 1997: Bereavement and grief in adults with learning disabilities. British Journal of Psychiatry: the Journal of Mental Science 170: 497-501

Goodkin, K.; Feaster, D.J.; Tuttle, R.; Blaney, N.T.; Kumar, M.; Baum, M.K.; Shapshak, P.; Fletcher, M.A. 1996: Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men. Clinical and Diagnostic Laboratory Immunology 3(1): 109-118

Brent, D.A.; Perper, J.; Moritz, G.; Allman, C.; Liotus, L.; Schweers, J.; Roth, C.; Balach, L.; Canobbio, R. 1993: Bereavement or depression? the impact of the loss of a friend to suicide. Journal of the American Academy of Child and Adolescent Psychiatry 32(6): 1189-1197

Neugebauer, R.; Rabkin, J.G.; Williams, J.B.; Remien, R.H.; Goetz, R.; Gorman, J.M. 1992: Bereavement reactions among homosexual men experiencing multiple losses in the AIDS epidemic. American Journal of Psychiatry 149(10): 1374-1379

Lovell, D.M.; Hemmings, G.; Hill, A.B. 1993: Bereavement reactions of female Scots and Swazis: a preliminary comparison. British Journal of Medical Psychology 66: 259-274

Nielsen, S.; Hahlin, M.; Möller, A.; Granberg, S. 1996: Bereavement, grieving and psychological morbidity after first trimester spontaneous abortion: comparing expectant management with surgical evacuation. Human Reproduction 11(8): 1767-1770

Karaman, T.; Ozkaynak, S.; Yaltkaya, K.; Büyükberker, C. 1997: Bereitschaftpotential in schizophrenia. British Journal of Psychiatry: the Journal of Mental Science 171: 31-34

Westphal, K.P.; Heinemann, H.A.; Grözinger, B.; Kotchoubey, B.J.; Diekmann, V.; Becker, W.; Kornhuber, H.H. 1998: Bereitschaftspotential in amyotrophic lateral sclerosis (ALS): Lower amplitudes in patients with hyperreflexia (spasticity). Acta Neurologica Scandinavica 98(1): 15-21

Trenkwalder, C.; Bucher, S.F.; Oertel, W.H.; Proeckl, D.; Plendl, H.; Paulus, W. 1993: Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroencephalography and Clinical Neurophysiology 89(2): 95-103

Bötzel, K.; Plendl, H.; Paulus, W.; Scherg, M. 1993: Bereitschaftspotential: Is there a contribution of the supplementary motor area?. Electroencephalography and Clinical Neurophysiology 89(3): 187-196

Portugal, J. 1994: Berenil acts as a poison of eukaryotic topoisomerase II. Febs Letters 344(2-3): 136-138

Durand, M.; Thuong, N.T.; Maurizot, J.C. 1994: Berenil complexation with a nucleic acid triple helix. Journal of Biomolecular Structure and Dynamics 11(6): 1191-1202

Barceló, F.; Portugal, J. 1993: Berenil recognizes and changes the characteristics of adenine and thymine polynucleotide structures. Biophysical Chemistry 47(3): 251-260

Mirzoyan, E.N. 1995: Berg's theory of nomogenesis: Experience in evolutionary synthesis. Izvestiya Akademii Nauk Seriya Biologicheskaya (Moscow) 1995(1): 110-118

Gloor, P.; Berger, H. 1994: Berger lecture. Is Berger's dream coming true?. Electroencephalography and Clinical Neurophysiology 90(4): 253-266

Nyffeler, R.; Eggli, U. 1996: Berger's Kakteen: The end of a nomenclatural nightmare in sight?. Taxon 45(2): 301-304

Tuschick, S.; Kirischuk, S.; Kirchhoff, F.; Liefeldt, L.; Paul, M.; Verkhratsky, A.; Kettenmann, H. 1997: Bergmann glial cells in situ express endothelinB receptors linked to cytoplasmic calcium signals. Cell Calcium 21(6): 409-419

Yuasa, S. 1996: Bergmann glial development in the mouse cerebellum as revealed by tenascin expression. Anatomy and Embryology 194(3): 223-234

Van-Voorhies, Wayne, A. 1996: Bergmann size clines: A simple explanation for their occurrence in ectotherms. Evolution 50(3): 1259-1264

Gringeri, A. 1994: Beriate-P study. Annals of Hematology 68(Suppl): S53-S54

San Sebastian, M.; Jativa, R. 1998: Beriberi in a well-nourished Amazonian population. Acta Tropica 70(2): 193-196

Youngman, P.M. 1994: Beringian ferrets: Mummies, biogeography, and systematics. Journal of Mammalogy 75(2): 454-461

Kowalczyk, J., K.; Krzeptowski, M. 1996: Berkshiria hungarica (Kertesz, 1921) and Neopachygaster meromelaena (Dufour, 1841) (Diptera, Stratiomyidae, Pachygasterinae) in Poland. Przeglad Zoologiczny 40(1-2): 79-81

Bowen, C.V.; Singer, S.; O'Brien, B.M. 1994: Bernard O'Brien: The microsurgical transfer of immature bone. Microsurgery 15(10): 733-737

Berndt, M.C.; Andrews, R.K. 2011: Bernard-Soulier syndrome. Haematologica 96(3): 355-359

Li, C.; Pasquale, D.N.; Roth, G.J. 1996: Bernard-Soulier syndrome with severe bleeding: absent platelet glycoprotein Ib alpha due to a homozygous one-base deletion. Thrombosis and Haemostasis 76(5): 670-674

Yeşilipek, M.A.; Karadoğan, I.; Undar, L. 1996: Bernard-Soulier syndrome: a flow cytometric analysis of membrane GP-Ib expression. Turkish Journal of Pediatrics 38(3): 375-379

Gengenbacher, D.; Tsakiris, D.A.; Tichelli, A.; Marbet, G.A.; Gratwohl, A.; Speck, B. 1996: Bernard-Soulier syndrome: Clinical significance of a rare bleeding disorder. Schweizerische Medizinische Wochenschrift 128(43): 1834-1841

Tomer, A.; Scharf, R.E.; McMillan, R.; Ruggeri, Z.M.; Harker, L.A. 1994: Bernard-Soulier syndrome: Quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements. European Journal of Haematology 52(4): 193-200

Lau, R.C.; Rinehart, K.L. 1994: Berninamycins B, C, and D, minor metabolites from Streptomyces bernensis. Journal of Antibiotics 47(12): 1466-1472

Schoedl, S. 1997: Berosus uhligi sp.n. from Namibia (Insecta: Coleoptera: Hydrophilidae). Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie 99: 333-336

Kis, B. 1992: Berotha fulva (Costa) (Neuroptera, Berothidae) new species for the fauna of Romania. Travaux du Museum National d'Histoire Naturelle "Grigore Antipa" 32: 73-75

Crossland, D.R.; Vander Kloet, S.P. 1996: Berry consumption by the American Robin, Turdus migratorius, and the subsequent effect on seed germination, plant vigour, and dispersal of the Lowbush Blueberry, Vaccinium angustifolium. Canadian Field-Naturalist 110(2): 303-309

Fougere Rifot, M.; Park, H.S.; Bouard, J. 1997: Berry pericarp ontogenesis from fertilization to maturity of Vitus vinifera L. var. Merlot. Journal International des Sciences de la Vigne et du Vin 31(3): 109-118

Abbruzzese, P.A.; Merlo, M.; Chiappa, E.; Bianco, R.; Ferrero, F.; Cappone, C.M. 1997: Berry syndrome, a complex aortopulmonary malformation: One-stage repair in a neonate. Annals of Thoracic Surgery 64(4): 1167-1169

Pinckers, A. 1992: Berson test for blue cone monochromatism. International Ophthalmology 16(3): 185-186

Denegri, G.M.; Perez-Serrano, J. 1997: Bertiellosis in man: a review of cases. Revista do Instituto de Medicina Tropical de Sao Paulo 39(2): 123-127

Faraci, W.S.; Zorn, S.H.; Bakker, A.V.; Jackson, E.; Pratt, K. 1993: Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation. Biochemical Journal 291: 369-374

Kreiss, K.; Wasserman, S.; Mroz, M.M.; Newman, L.S. 1993: Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 35(3): 267-274

Kuang, B.; Rubenstein, P.A. 1997: Beryllium fluoride and phalloidin restore polymerizability of a mutant yeast actin (V266G,L267G) with severely decreased hydrophobicity in a subdomain 3/4 loop. Journal of Biological Chemistry 272(2): 1237-1247

Ledvina, R.; Kolar, L. 1997: Beryllium in soils and plants in a region of energy industry emissions. Sbornik Jihoceska Univerzita Zemedelska Fakulta Ceske Budejovice Fytotechnicka Rada 14(1): 23-28

Papastefanou, C.; Ioannidou, A. 1996: Beryllium-7 aerosols in ambient air. Environment International 22(Suppl 1): S125-S130

Mathur, S.; Flora, S.J.; Mathur, R.; Kannan, G.M.; Das Gupta, S. 1994: Beryllium-induced biochemical alterations and their prevention following co-administration of meso-2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane sulphonate in rats. Journal of Applied Toxicology: Jat 14(4): 263-267

Pfeifer, S.; Bartlett, R.; Strausz, J.; Haller, S.; Müller-Quernheim, J. 1994: Beryllium-induced disturbances of the murine immune system reflect some phenomena observed in sarcoidosis. International Archives of Allergy and Immunology 104(4): 332-339

Tinkle, S.S.; Newman, L.S. 1997: Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. American Journal of Respiratory and Critical Care Medicine 156(6): 1884-1891

Turner, B.L. 1993: Berylsimpsonia, new genus (Asteraceae: Mutisieae) of the Greater Antilles. Phytologia 74(5): 349-355

Woods-Kettelberger, A.T.; Smith, C.P.; Corbett, R.; Szewczak, M.R.; Roehr, J.E.; Bores, G.M.; Klein, J.T.; Kongsamut, S. 1996: Besipirdine (HP 749) reduces schedule-induced polydipsia in rats. Brain Research Bulletin 41(2): 125-130

Baskin, J., M.; Baskin, C., C. 1996: Bessey Picklesimer's little-known quantitative study on the vegetation of a cedar glade in the central basin of Tennessee. Castanea 61(1): 25-37

Cuerrier, A.; Barabe, D.; Brouillet, L. 1992: Bessey and Engler: A numerical analysis of their classification of the flowering plants. Taxon 41(4): 667-684

Morrell, S.; Kerr, C.; Driscoll, T.; Taylor, R.; Salkeld, G.; Corbett, S. 1998: Best estimate of the magnitude of mortality due to occupational exposure to hazardous substances. Occupational and Environmental Medicine 55(9): 634-641

Slavin, R.E. 1995: Best evidence synthesis: An intelligent alternative to meta-analysis. Journal of Clinical Epidemiology 48(1): 9-18

Gaur, G.K.; Raheja, K.L. 1996: Best linear unbiased estimates of different environmental effects for production and reproduction traits in Sahiwal. Indian Journal of Animal Sciences 66(6): 603-606

Saito, S.; Matsuda, H.; Iwaisaki, H. 1998: Best linear unbiased prediction of additive genetic merit using a combined-merit sire and dam model for marker-assisted selection. Genes and Genetic Systems 73(1): 65-69

Aust, W.Michael 1994: Best management practices for forested wetlands in the southern Appalachian Region. Water Air and Soil Pollution 77(3-4): 457-468

Weber, B.H.; Walker, D.; Müller, B.; Mar, L. 1994: Best's vitelliform dystrophy (VMD2) maps between D11S903 and PYGM: no evidence for locus heterogeneity. Genomics 20(2): 267-274

Fennig, S.; Craig, T.; Lavelle, J.; Kovasznay, B.; Bromet, E.J. 1994: Best-estimate versus structured interview-based diagnosis in first-admission psychosis. Comprehensive Psychiatry 35(5): 341-348

Cunningham, C.W.; Zhu, H.; Hillis, D.M. 1998: Best-fit maximum-likelihood models for phylogenetic inference: Empirical tests with known phylogenies. Evolution 52(4): 978-987

Chung, M.C.; Lee, H.J.; Chun, H.K.; Lee, C.H.; Kim, S.I.; Kho, Y.H. 1996: Bestatin analogue from Streptomyces neyagawaensis SL-387. Bioscience Biotechnology and Biochemistry 60(5): 898-900

Mathe, G.; Itzhaki, M.; Orbach Arbouys, S. 1993: Bestatin specifically enhances the number of CD4+ T cells in peripheral blood in patients whose CD8+ T cell numbers are also depressed. International Journal of Immunotherapy 9(3): 165-167

Takano, M.; Tomita, Y.; Katsura, T.; Yasuhara, M.; Inui, K.; Hori, R. 1994: Bestatin transport in rabbit intestinal brush-border membrane vesicles. Biochemical Pharmacology 47(6): 1089-1090

Inoue, T.; Kanzaki, H.; Imai, K.; Narukawa, S.; Higuchi, T.; Katsuragawa, H.; Maeda, M.; Mori, T. 1994: Bestatin, a potent aminopeptidase-N inhibitor, inhibits in vitro decidualization of human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism 79(1): 171-175

Szczepanska, R.; Grupp, L.A. 1993: Bestatin, an aminopeptidase B inhibitor, selectively reduces alcohol intake in rats. Alcoholism Clinical and Experimental Research 17(2): 434-437

Stone, S.; Sacher, M.; Mao, Y.; Carr, C.; Lyons, P.; Quinn, A.M.; Ferro-Novick, S. 1997: Bet1p activates the v-SNARE Bos1p. Molecular Biology of the Cell 8(7): 1175-1181

Konder Anasz, Z.; Mertas, A.; Respondek, S. 1996: Beta - 2 microglobulin level in pregnancy. Central-European Journal of Immunology 21(2): 146-149

Divers, M.J.; Bulmer, J.N.; Miller, D.; Lilford, R.J. 1995: Beta 1 integrins in third trimester human placentae: no differential expression in pathological pregnancy. Placenta 16(3): 245-260

Ronco, C.; Heifetz, A.; Fox, K.; Curtin, C.; Brendolan, A.; Gastaldon, F.; Crepaldi, C.; Fortunato, A.; Pietribasi, G.; Caberlotto, A.; Brunello, A.; Milan Manani, S.; Zanella, M.; La Greca, G. 1997: Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule. International Journal of Artificial Organs 20(3): 136-143

Ahluwalia, N.K.; Thompson, D.G.; Barlow, J.; Heggie, L. 1994: Beta adrenergic modulation of human upper intestinal propulsive forces. Gut 35(10): 1356-1359

Chester, M.R.; Amadi, A.A.; Barnett, D.B. 1995: Beta adrenoceptor density in the donor heart: a guide to prognosis?. British Heart Journal 73(6): 540-543

Larosa, G.; Armstrong, P.W.; Seeman, P.; Forster, C. 1993: Beta adrenoceptor recovery after heart failure in the dog. Cardiovascular Research 27(3): 489-493

Hall, J.A.; Ferro, A.; Dickerson, J.E.; Brown, M.J. 1993: Beta adrenoreceptor subtype cross regulation in the human heart. British Heart Journal 69(4): 332-337

Kopp, A.; Stanton, R.C. 1997: Beta Amyloid does not activate the antioxidant pentose phosphate pathway within the B12 neural cell line. Neuroreport 8(5): 1197-1201

Roberts, G.W.; Gentleman, S.M.; Lynch, A.; Murray, L.; Landon, M.; Graham, D.I. 1994: Beta Amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 57(4): 419-425

Kurrer, M.O.; Pakala, S.V.; Hanson, H.L.; Katz, J.D. 1997: Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America 94(1): 213-218

Taub, D.D.; Ortaldo, J.R.; Turcovski-Corrales, S.M.; Key, M.L.; Longo, D.L.; Murphy, W.J. 1996: Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. Journal of Leukocyte Biology 59(1): 81-89

Harland, J.J. 1993: Beta Fibre: A case history. International Journal of Food Sciences and Nutrition 44(Suppl 1): S87-S96

Behague, I.; Poirier, O.; Nicaud, V.; Evans, A.; Arveiler, D.; Luc, G.; Cambou, J.-Pierre; Scarabin, P.-Yves; Bara, L.; Green, F.; Cambien, F. 1996: Beta Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: The ECTIM Study. Circulation 93(2): 440-449

Dusenbery, K.E.; Alul, I.H.; Holland, E.J.; Khan, F.M.; Levitt, S.H. 1992: Beta irradiation of recurrent ptergia: results and complications. International Journal of Radiation Oncology Biology Physics 24(2): 315-320

Zhao, X.M.; Montet, A.M.; Montet, J.C. 1993: Beta Muricholic acid: A new hepatoprotective agent. Journal of Nutritional Biochemistry 4(2): 105-112

Heidaran, M.A.; Mahadevan, D.; Larochelle, W.J. 1995: Beta PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 9(1): 140-145

Omote, H.; Le, N.P.; Park, M.Y.; Maeda, M.; Futai, M. 1995: Beta subunit Glu-185 of Escherichia coli H(+)-ATPase (ATP synthase) is an essential residue for cooperative catalysis. Journal of Biological Chemistry 270(43): 25656-25660

Pichler, M.; Cassidy, T.N.; Reimer, D.; Haase, H.; Kraus, R.; Ostler, D.; Striessnig, J. 1997: Beta subunit heterogeneity in neuronal L-type Ca2+ channels. Journal of Biological Chemistry 272(21): 13877-13882

Tadmor, Y.; Bergstein, M.; Skaliter, R.; Shwartz, H.; Livneh, Z. 1994: Beta subunit of DNA polymerase III holoenzyme is induced upon ultraviolet irradiation or nalidixic acid treatment of Escherichia coli. Mutation Research 308(1): 53-64

Broillet, M.C.; Firestein, S. 1997: Beta subunits of the olfactory cyclic nucleotide-gated channel form a nitric oxide activated Ca2+ channel. Neuron 18(6): 951-958

Rüdiger, M.; Plessmann, U.; Rüdiger, A.H.; Weber, K. 1995: Beta tubulin of bull sperm is polyglycylated. Febs Letters 364(2): 147-151

Holschneider, D.P.; Leuchter, A.F. 1995: Beta activity in aging and dementia. Brain Topography 8(2): 169-180

Mansier, P.; Chevalier, B.; Barnett, D.B.; Swynghedauw, B. 1993: Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat. Pflugers Archiv: European Journal of Physiology 424(3-4): 354-360

Patel, J.J.; Dyer, R.B.; Mitha, A.S. 1995: Beta adrenergic blockade does not improve effort tolerance in patients with mitral stenosis in sinus rhythm. European Heart Journal 16(9): 1264-1268

Wagner, J.P.; Seidler, F.J.; Schachat, F.H.; Slotkin, T.A. 1994: beta Adrenergic control of c-fos protooncogene expression in developing rat brain regions. Journal of Pharmacology and Experimental Therapeutics 269(3): 1292-1299

Munoz, N.M.; Vita, A.J.; Neeley, S.P.; McAllister, K.; Spaethe, S.M.; White, S.R.; Leff, A.R. 1994: Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. Journal of Pharmacology and Experimental Therapeutics 268(1): 139-143

Khac, L.D.; Arnaudeau, S.; Lepretre, N.; Mironneau, J.; Harbon, S. 1996: Beta adrenergic receptor activation attenuates the generation of inositol phosphates in the pregnant rat myometrium. Correlation with inhibition of Ca++ influx, a cAMP-independent mechanism. Journal of Pharmacology and Experimental Therapeutics 276(1): 130-136

Watanabe, M.; Hatta, S.; Lazarevic, M.B.; Saito, T.; Rasenick, M.M. 1995: Beta adrenergic receptor assay in permeable cells. Biogenic Amines 11(3): 235-245

Ruan, Y.; Kan, H.; Malik, K.U. 1997: Beta adrenergic receptor stimulated prostacyclin synthesis in rabbit coronary endothelial cells is mediated by selective activation of phospholipase D: inhibition by adenosine 3'5'-cyclic monophosphate. Journal of Pharmacology and Experimental Therapeutics 281(3): 1038-1046

Murugaiah, K.D.; O'Donnell, J.M. 1995: Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices. Research Communications in Molecular Pathology and Pharmacology 90(2): 179-190

Freund, R.K.; Palmer, M.R. 1997: Beta adrenergic sensitization of gamma-aminobutyric acid receptors to ethanol involves a cyclic AMP/protein kinase a second-messenger mechanism. Journal of Pharmacology and Experimental Therapeutics 280(3): 1192-1200

Hajj-Ali, A.F.; Wong, P.C. 1993: Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan. Journal of Pharmacology and Experimental Therapeutics 267(3): 1423-1427

Stone, E.A.; Manavalan, S.J.; Zhang, Y.; Quartermain, D. 1995: Beta adrenoceptor blockade mimics effects of stress on motor activity in mice. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 12(1): 65-71

Genaro, Ana-Maria; Sterin-Borda, Leonor; Sborda, Enri 1993: Beta adrenoceptors in murine lymphocyte subpopulations: Differential responsiveness to isoprenaline stimulation. Molecular Neuropharmacology 3(2): 101-107

Harrigan, M.R.; Kunkel, D.D.; Nguyen, L.B.; Malouf, A.T. 1995: Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiology of Aging 16(5): 779-789

Liu, Y.; Dargusch, R.; Schubert, D. 1997: Beta amyloid toxicity does not require RAGE protein. Biochemical and Biophysical Research Communications 237(1): 37-40

Hill, M.A.; Gunning, P. 1993: Beta and gamma actin mRNAs are differentially located within myoblasts. Journal of Cell Biology 122(4): 825-832

Kennedy, H.L. 1997: Beta blockade, ventricular arrhythmias, and sudden cardiac death. American Journal of Cardiology 80(9b): 29J-34J

Gillette, D.W.; Tannery, L.P. 1994: Beta blocker inhibits tricyclic metabolism. Journal of the American Academy of Child and Adolescent Psychiatry 33(2): 223-224

Love, J.N. 1994: Beta blocker toxicity after overdose: when do symptoms develop in adults?. Journal of Emergency Medicine 12(6): 799-802

Sial, S.H.; Malone, M.; Freeman, J.L.; Battiola, R.; Nachodsky, J.; Goodwin, J.S. 1994: Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction. Journal of General Internal Medicine 9(11): 599-605

Crichton, F. 1996: Beta blockers in pregnancy and their effect on regional Doppler ultrasound and fetal weight. Clinical and Experimental Obstetrics and Gynecology 23(1): 15-17

Glueck, C.J.; Glueck, H.I.; Hamer, T.; Speirs, J.; Tracy, T.; Stroop, D. 1994: Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activity. American Journal of the Medical Sciences 307(5): 317-324

Ljunggren, K.; Strand, S.E.; Ceberg, C.P.; Sjöholm, H.; Elmqvist, D.; Brun, A.; Salford, L.G. 1993: Beta camera low activity tumor imaging. Acta Oncologica 32(7-8): 869-872

Guillausseau, P.J. 1994: Beta cell dysfunction and Type 2 diabetes: Current concepts. Diabete and Metabolisme 20(3 Suppl): 325-329

Gaskins, H.R.; Prochazka, M.; Hamaguchi, K.; Serreze, D.V.; Leiter, E.H. 1992: Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. Journal of Clinical Investigation 90(6): 2220-2227

Montaña, E.; Bonner-Weir, S.; Weir, G.C. 1993: Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. Journal of Clinical Investigation 91(3): 780-787

Myrsén, U.; Keymeulen, B.; Pipeleers, D.G.; Sundler, F. 1996: Beta cells are important for islet innervation: evidence from purified rat islet-cell grafts. Diabetologia 39(1): 54-59

Pang, K.; Mukonoweshuro, C.; Wong, G.G. 1994: Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proceedings of the National Academy of Sciences of the United States of America 91(20): 9559-9563

Croyle, M.A.; Roessler, B.J.; Hsu, C.P.; Sun, R.; Amidon, G.L. 1998: Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharmaceutical Research 15(9): 1348-1355

Itow, S. 1995: Beta diversity of altitudinal vegetation zonation in Japan. Japanese Journal of Ecology 45(2): 99-111

Brennan, B.J.; Rink, W.J.; Mcguirl, E.L.; Schwarcz, H.P.; Prestwich, W.V. 1997: Beta doses in tooth enamel by one-group theory and the ROSY ESR dating software. Radiation Measurements 27(2): 307-314

Palocaren, T.; Mathai, E.; Brahmadathan, K.N.; John, T.J.; Balasubramaniam, N.; Nath, V. 1994: Beta haemolytic group A streptococci causing urinary tract infection. British Journal of Urology 74(4): 444-446

Syrigos, K.N.; Fyssas, I.; Konstandoulakis, M.M.; Harrington, K.J.; Papadopoulos, S.; Milingos, N.; Peveretos, P.; Golematis, B.C. 1998: Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma. Gut 42(1): 88-91

Stancato, L.F.; Sakatsume, M.; David, M.; Dent, P.; Dong, F.; Petricoin, E.F.; Krolewski, J.J.; Silvennoinen, O.; Saharinen, P.; Pierce, J.; Marshall, C.J.; Sturgill, T.; Finbloom, D.S.; Larner, A.C. 1997: Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Molecular and Cellular Biology 17(7): 3833-3840

Iurlaro, M.; Benelli, R.; Masiello, L.; Rosso, M.; Santi, L.; Albini, A. 1998: Beta Interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid. European Journal of Cancer 34(4): 570-576

Rödel, J.; Groh, A.; Vogelsang, H.; Lehmann, M.; Hartmann, M.; Straube, E. 1998: Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. Infection and Immunity 66(9): 4491-4495

Westerberg, G.; Lundqvist, H.; Kilar, F.; Langstrom, B. 1993: Beta positive-selective radiodetector for capillary electrophoresis. Journal of Chromatography 645(2): 319-325

Gardella, J.E.; Gorgone, G.A.; Munoz, P.C.; Ghiso, J.; Frangione, B.; Gorevic, P.D. 1992: Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease. Laboratory Investigation; A Journal of Technical Methods and Pathology 67(3): 303-313

Sandhofer, C.; Schwartz, H.L.; Mariash, C.N.; Forrest, D.; Oppenheimer, J.H. 1998: Beta receptor isoforms are not essential for thyroid hormone-dependent acceleration of PCP-2 and myelin basic protein gene expression in the developing brains of neonatal mice. Molecular and Cellular Endocrinology 137(2): 109-115

Becker, P.S.; Tse, W.T.; Lux, S.E.; Forget, B.G. 1993: Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. Journal of Clinical Investigation 92(2): 612-616

Zamponi, G.W.; Soong, T.W.; Bourinet, E.; Snutch, T.P. 1996: Beta subunit coexpression and the alpha1 subunit domain I-II linker affect piperidine block of neuronal calcium channels. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(8): 2430-2443

Scott, V.E.; De Waard, M.; Liu, H.; Gurnett, C.A.; Venzke, D.P.; Lennon, V.A.; Campbell, K.P. 1996: Beta subunit heterogeneity in N-type Ca2+ channels. Journal of Biological Chemistry 271(6): 3207-3212

Smith, V.; Verhey, L.; Wara, W.; Harsh, G.; Larson, D. 1993: Beta test site report: gamma plan. Stereotactic and Functional Neurosurgery 61 Suppl. 1: 116-123

Stenbeck, G.; Harter, C.; Brecht, A.; Herrmann, D.; Lottspeich, F.; Orci, L.; Wieland, F.T. 1993: Beta'-COP, a novel subunit of coatomer. EMBO Journal 12(7): 2841-2845

Fornai, F.; Alessandri, M.G.; Saginario, A.; Vaglini, F.; Corsini, G.U. 1993: beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP. Brain Research 605(1): 93-100

Mitsuishi, K.; Takahashi, A.; Mizutani, M.; Ochiai, K.; Itakura, C. 1993: Beta,beta'-Iminodipropionitrile toxicity in normal and congenitally neurofilament-deficient Japanese quails. Acta Neuropathologica 86(6): 578-581

Roitman, J.N.; Wollenweber, E. 1993: Beta,beta-Dimethacrylophenones and a chromanone from Nama hispidum and Nama johnstonii. Phytochemistry 33(4): 936-938

Soutto, M.; Guerrero, J.M.; Molinero, P. 1996: Beta- and alpha-adrenergic mechanisms are involved in regulating type II thyroxine 5'-deiodinase in rat thymus. Life Sciences 58(1): 1-8

Ferro, A.; Kaumann, A.J.; Brown, M.J. 1993: Beta 1- and beta 2-adrenoceptor-mediated relaxation in human internal mammary artery and saphenous vein: unchanged beta- and alpha-adrenoceptor responsiveness after chronic beta 1-adrenoceptor blockade. British Journal of Pharmacology 109(4): 1053-1058

Cerrato, A.; Fulciniti, F.; Avallone, A.; Benincasa, G.; Palombini, L.; Grieco, M. 1998: Beta- and gamma-catenin expression in thyroid carcinomas. Journal of Pathology 185(3): 267-272

Skaliter, R.; Bergstein, M.; Livneh, Z. 1996: Beta*, a UV-inducible shorter form of the beta subunit of DNA polymerase III of Escherichia coli. II. Overproduction, purification, and activity as a polymerase processivity clamp. Journal of Biological Chemistry 271(5): 2491-2496

Paz-Elizur, T.; Skaliter, R.; Blumenstein, S.; Livneh, Z. 1996: Beta*, a UV-inducible smaller form of the beta subunit sliding clamp of DNA polymerase III of Escherichia coli. I. Gene expression and regulation. Journal of Biological Chemistry 271(5): 2482-2490

Klentzeris, L.D.; Bulmer, J.N.; Trejdosiewicz, L.K.; Morrison, L.; Cooke, I.D. 1993: Beta-1 integrin cell adhesion molecules in the endometrium of fertile and infertile women. Human Reproduction 8(8): 1223-1230

Hieken, T.J.; Ronan, S.G.; Farolan, M.; Shilkaitis, A.L.; Kim, D.K.; Das Gupta, T.K. 1995: Beta 1 integrin expression in malignant melanoma predicts occult lymph node metastases. Surgery 118(4): 669-73; Discussion 673-5

Lieberthal, W.; McKenney, J.B.; Kiefer, C.R.; Snyder, L.M.; Kroshian, V.M.; Sjaastad, M.D. 1997: Beta1 integrin-mediated adhesion between renal tubular cells after anoxic injury. Journal of the American Society of Nephrology: Jasn 8(2): 175-183

Baraldi, A.; Zambruno, G.; Furci, L.; Manca, V.; Vaschieri, C.; Lusvarghi, E. 1994: Beta-1 integrins in the normal human glomerular capillary wall: an immunoelectron microscopy study. Nephron 66(3): 295-301

Mcainsh, J.; Davis, J.M.; Cruickshank, J.M. 1992: Beta-1 selectivity, antihypertensive effect and the frequency of stroke. Acta Therapeutica 18(4): 373-419

Jouault, T.; Lepage, G.; Bernigaud, A.; Trinel, P.A.; Fradin, C.; Wieruszeski, J.M.; Strecker, G.; Poulain, D. 1995: Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infection and Immunity 63(6): 2378-2381

Fradin, C.; Jouault, T.; Mallet, A.; Mallet, J.M.; Camus, D.; Sinaÿ, P.; Poulain, D. 1996: Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. Journal of Leukocyte Biology 60(1): 81-87

Duvic, B.; Soderhall, K. 1993: Beta-1,3-Glucan-binding proteins from plasma of the fresh-water crayfishes Astacus astacus and Procambarus clarkii. Journal of Crustacean Biology 13(3): 403-408

Egea, C.; Alcazar, M.D.; Candela, M.E. 1996: Beta-1,3-Glucanase and chitinase as pathogenesis-related proteins in the defense reaction of two Capsicum annuum cultivars infected with cucumber mosaic virus. Biologia Plantarum 38(3): 437-443

Hincha, D.K.; Meins, F.; Schmitt, J.M. 1997: Beta]-1,3-Glucanase Is Cryoprotective in Vitro and Is Accumulated in Leaves during Cold Acclimation. Plant Physiology 114(3): 1077-1083

Chye, M.L.; Cheung, K.Y. 1995: beta-1,3-Glucanase is highly-expressed in laticifers of Hevea brasiliensis. Plant Molecular Biology 29(2): 397-402

Ernst, D.; Bodemann, A.; Schmelzer, E.; Langerbartels, C.; Sandermann, H.,. Jr.; 1996: Beta-1,3-Glucanase mRNA is locally, but not systemically induced in Nicotiana tabacum L. cv. BEL W3 after ozone fumigation. Journal of Plant Physiology 148(1-2): 215-221

Churngchow, N.; Suntaro, A.; Wititsuwannakul, R. 1995: Beta-1,3-glucanase isozymes from the latex of Hevea brasiliensis. Phytochemistry 39(3): 505-509

Helton, T.E.; Magner, J.A. 1994: Beta-1,4-galactosyltransferase and alpha-mannosidase-Ii messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice. Endocrinology 135(5): 1980-1985

Jaskiewicz, E.; Zhu, G.; Bassi, R.; Darling, D.S.; Young, W.W. 1996: Beta1,4-N-acetylgalactosaminyltransferase (GM2 synthase) is released from Golgi membranes as a neuraminidase-sensitive, disulfide-bonded dimer by a cathepsin D-like protease. Journal of Biological Chemistry 271(42): 26395-26403

Sango, K.; Johnson, O.N.; Kozak, C.A.; Proia, R.L. 1995: beta-1,4-N-Acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene. Genomics 27(2): 362-365

Hidari, J.K.; Ichikawa, S.; Furukawa, K.; Yamasaki, M.; Hirabayashi, Y. 1994: Beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F. Biochemical Journal 303: 957-965

Zhou, X.M.; Feussner, G.K.; Fishman, P.H. 1993: Beta(1)-Adrenergic and D(1) Dopaminergic Receptors in Human Neurotumor Cells: Differences in Spare Receptors and Desensitization of Adenylyl Cyclase. Molecular and Cellular Neurosciences 4(1): 74-82

Gillespie, D.D.; Duhl, D.M.; Manier, D.H.; Sulser, F. 1995: Beta-1-Adrenoceptor mRNA levels can be increased via beta-adrenoceptor-independent events. Journal of Pharmacy and Pharmacology 47(1): 62-65

Shiraishi, S.; Okamura, T.; Toda, N. 1997: beta1-Adrenoceptor-mediated relaxation by norepinephrine in dog hepatic arteries. Japanese Journal of Pharmacology 73(1): 101-103

Lamont, L.S.; Romito, R.A.; Finkelhor, R.S.; Kalhan, S.C. 1997: Beta 1-adrenoreceptors regulate resting metabolic rate. Medicine and Science in Sports and Exercise 29(6): 769-774

Van der Velde-Zimmerman, D.; Smits, A.J.; Verdaasdonk, M.A.; Rademakers, L.H.; Werner, N.; Spierings, D.C.; De Weger, R.A.; Van den Tweel, J.G.; Joling, P. 1996: Beta1-Integrins dominate cell traffic of leukemic cells in human bone-marrow stroma. International Journal of Cancer 66(2): 225-233

Cacciola, R.R.; Stagno, F.; Impera, S.; Assisi, A.R.; Cacciola, E.; Guglielmo, P. 1997: Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34. Acta Haematologica 97(1-2): 63-66

Yoshikawa, T.; Handa, S.; Akaishi, M.; Mitamura, H.; Ogawa, S. 1995: Beta-1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for idiopathic dilated cardiomyopathy. Cardiology 86(3): 217-223

Mcnally, T.; Mackie, I.J.; Isenberg, D.A.; Machin, S.J. 1996: Beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndrome. Thrombosis and Haemostasis 76(2): 220-225

Tipping, P.G.; Cornthwaite, L.J.; Holdsworth, S.R. 1994: Beta-2 Integrin independent neutrophil recruitment and injury in anti-GBM glomerulonephritis in rabbits. Immunology and Cell Biology 72(6): 471-479

Cheung, A.K.; Parker, C.J.; Hohnholt, M. 1993: Beta2 integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney International 43(3): 649-660

Piwowar, E.M.; Tugume, S.B.; Grant, R.M.; Lutalo, T.; Pattishall, K.; Katongole-Mbidde, E. 1995: beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans. Clinical and Diagnostic Laboratory Immunology 2(2): 236-237

Johnson, P.W.; Whelan, J.; Longhurst, S.; Stepniewska, K.; Matthews, J.; Amess, J.; Norton, A.; Rohatiner, A.Z.; Lister, T.A. 1993: Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. British journal of cancer 67(4): 792-797

Skeberdis, V.A.; Jurevicius, J.; Fischmeister, a.R. 1997: Beta-2 adrenergic activation of L-type Ca++ current in cardiac myocytes. Journal of Pharmacology and Experimental Therapeutics 283(2): 452-461

Ohe, M.; Munakata, M.; Hizawa, N.; Itoh, A.; Doi, I.; Yamaguchi, E.; Homma, Y.; Kawakami, Y. 1995: Beta 2 adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma. Thorax 50(4): 353-359

Walzog, B.; Offermanns, S.; Zakrzewicz, A.; Gaehtgens, P.; Ley, K. 1996: Beta2 integrins mediate protein tyrosine phosphorylation in human neutrophils. Journal of Leukocyte Biology 59(5): 747-753

Rothenberg, B.E.; Voland, J.R. 1996: beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proceedings of the National Academy of Sciences of the United States of America 93(4): 1529-1534

Sabin, C.A.; Phillips, A.N.; Lee, C.A.; Elford, J.; Timms, A.; Bofill, M.; Janossy, G. 1994: Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: A proposed strategy for use in clinical care. British Journal of Haematology 86(2): 366-371

Lewandowski, B.; Bernacka, K.; Kucharewicz, B.; Szmitkowski, M.; Klimiuk, P.A. 1995: Beta-2 microglobulin in rheumatoid arthritis. Reumatologia 33(2): 121-128

Skedros, D.G.; Cass, S.P.; Hirsch, B.E.; Kelly, R.H. 1993: Beta-2 transferrin assay in clinical management of cerebral spinal fluid and perilymphatic fluid leaks. Journal of Otolaryngology 22(5): 341-344

Billman, G.E.; Castillo, L.C.; Hensley, J.; Hohl, C.M.; Altschuld, R.A. 1997: Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96(6): 1914-1922

Mills, P.J.; Dimsdale, J.E.; Coy, T.V.; Ancoli-Israel, S.; Clausen, J.L.; Nelesen, R.A. 1995: Beta 2-adrenergic receptor characteristics in sleep apnea patients. Sleep 18(1): 39-42

January, B.; Seibold, A.; Whaley, B.; Hipkin, R.W.; Lin, D.; Schonbrunn, A.; Barber, R.; Clark, R.B. 1997: beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. Journal of Biological Chemistry 272(38): 23871-23879

Verleden, G.M.; Belvisi, M.G.; Rabe, K.F.; Miura, M.; Barnes, P.J. 1993: Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. Journal of Applied Physiology 74(3): 1195-1199

Stewart, A., G.; Tomlinson, P., R.; Wilson, J., W. 1997: Beta-2-Adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: Importance of the duration of beta-2-adrenoceptor stimulation. British Journal of Pharmacology 121(3): 361-368

Kotanko, P.; Hoeglinger, O.; Skrabal, F. 1992: Beta-2-Adrenoceptor density in fibroblast culture correlates with human sodium chloride sensitivity. American Journal of Physiology 263(3 Part 1): C623-C627

Von Mandach, Ursula 1994: Beta-2-Adrenoceptors and cyclic AMP in lymphocytes and their relationship to uterine contractility. Zeitschrift für Geburtshilfe und Perinatologie 198(5-6): 201-203

Moummi, C.; Magous, R.; Bali, J.P.erre 1992: Beta-2-Adrenoceptors mediate inhibition of carbachol-induced contraction and cAMP generation in isolated smooth muscle cells from rabbit gastric antrum. Drug Development Research 27(2): 137-145

Panina-Bordignon, P.; Mazzeo, D.; Lucia, P.D.; D'Ambrosio, D.; Lang, R.; Fabbri, L.; Self, C.; Sinigaglia, F. 1997: Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. Journal of Clinical Investigation 100(6): 1513-1519

Groussac, M.H.; Bendaoud, B.; Adler, Y.; Lamour, A.; Youinou, P. 1994: Beta-2-Glycoprotein I enhances phospholipid binding activity in individuals infected with type 1 human immunodeficiency virus. International Journal of Immunopathology and Pharmacology 7(1): 1-6

Simon, S.I.; Rochon, Y.P.; Lynam, E.B.; Smith, C.W.; Anderson, D.C.; Sklar, L.A. 1993: Beta 2-integrin and L-selectin are obligatory receptors in neutrophil aggregation. Blood 82(4): 1097-1106

Christianson, G.J.; Blankenburg, R.L.; Duffy, T.M.; Panka, D.; Roths, J.B.; Marshak-Rothstein, A.; Roopenian, D.C. 1996: Beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. Journal of Immunology 156(12): 4932-4939

Gillissen, A.; Jaworska, M.; Schärling, B.; van Zwoll, D.; Schultze-Werninghaus, G. 1997: Beta-2-agonists have antioxidant function in vitro. 1. Inhibition of superoxide anion, hydrogen peroxide, hypochlorous acid and hydroxyl radical. Respiration; International Review of Thoracic Diseases 64(1): 16-22

Gillissen, A.; Wickenburg, D.; van Zwoll, D.; Schultze-Werninghaus, G. 1997: Beta-2-agonists have antioxidant function in vitro. 2. the effect of beta-2-agonists on oxidant-mediated cytotoxicity and on superoxide anion generated by human polymorphonuclear leukocytes. Respiration; International Review of Thoracic Diseases 64(1): 23-28

Caloca, M.J.; Fernandez, N.; Lewin, N.E.; Ching, D.; Modali, R.; Blumberg, P.M.; Kazanietz, M.G. 1997: Beta2-chimaerin is a high affinity receptor for the phorbol ester tumor promoters. Journal of Biological Chemistry 272(42): 26488-26496

Brighton, T.A.; Hogg, P.J.; Dai, Y.P.; Murray, B.H.; Chong, B.H.; Chesterman, C.N. 1996: Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. British Journal of Haematology 93(1): 185-194

Kolenic, J.; Zimacek, J.; Petrovicova, J.; Zemberova, E.; Machanova, Y.; Jurgova, T. 1997: Beta-2-microglobulin - biological marker of the toxic effects of metals?. Pracovni Lekarstvi 49(3): 109-112

Graham, N.M.; Rubb, S.; Hoover, D.R.; McCall, L.D.; Palenicek, J.G.; Saah, A.J. 1994: Beta 2-microglobulin and other early predictors of human immunodeficiency virus type 1-related wasting. Annals of Epidemiology 4(1): 32-39

Ripoll, E.; Arribas, I.; Relea, P.; Varela, L.; Villa, L.F.; Revilla, M.; Rico, H. 1995: Beta-2-microglobulin in diseases with high bone remodeling. Calcified Tissue International 57(4): 272-276

Malaguarnera, M.; Anastasio, C.; Rosso, G.; Siciliano, R.; Trovato, B.A.riana 1995: Beta-2-microglobulin levels before and after interferon treatment in patients with chronic hepatitis C. Current Therapeutic Research 56(3): 269-279

Nandapalan, V.; Watson, I.D.; Swift, A.C. 1996: Beta-2-transferrin and cerebrospinal fluid rhinorrhoea. Clinical Otolaryngology and Allied Sciences 21(3): 259-264

Takahashi, H.; Yoshida, T.; Nishimura, M.; Nakanishi, T.; Kondo, M.; Yoshimura, M. 1992: Beta-3 adrenergic agonist, BRL-26830A, and alpha/beta blocker, arotinolol, markedly increase regional blood flow in the brown adipose tissue in anesthetized rats. Japanese Circulation Journal 56(9): 936-942

Dolan, J.A.; Muenkel, H.A.; Burns, M.G.; Pellegrino, S.M.; Fraser, C.M.; Pietri, F.; Strosberg, A.D.; Largis, E.E.; Dutia, M.D.; Bloom, J.D. 1994: Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. Journal of Pharmacology and Experimental Therapeutics 269(3): 1000-1006

Berlan, M.; Galitzky, J.; Bousquet-Melou, A.; Lafontan, M.; Montastruc, J.L. 1994: Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. Journal of Pharmacology and Experimental Therapeutics 268(3): 1444-1451

Hieken, T.J.; Farolan, M.; Ronan, S.G.; Shilkaitis, A.; Wild, L.; Das Gupta, T.K. 1996: Beta3 integrin expression in melanoma predicts subsequent metastasis. Journal of Surgical Research 63(1): 169-173

Oriowo, M.A. 1997: Beta(3)-adrenoceptors mediate smooth muscle relaxation in the rat lower oesophageal sphincter. Journal of Autonomic Pharmacology 17(3): 175-182

Hinney, A.; Lentes, K.U.; Rosenkranz, K.; Barth, N.; Roth, H.; Ziegler, A.; Hennighausen, K.; Coners, H.; Wurmser, H.; Jacob, K.; Römer, G.; Winnikes, U.; Mayer, H.; Herzog, W.; Lehmkuhl, G.; Poustka, F.; Schmidt, M.H.; Blum, W.F.; Pirke, K.M.; Schäfer, H.; Grzeschik, K.H.; Remschmidt, H.; Hebebrand, J. 1997: Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 21(3): 224-230

Martin, C.A.; Advenier, C. 1995: Beta 3-adrenoceptors and airways. Fundamental and Clinical Pharmacology 9(2): 114-118

Berlan, M.; Galitzky, J.; Montastruc, J.L. 1995: Beta 3-adrenoceptors in the cardiovascular system. Fundamental and Clinical Pharmacology 9(3): 234-239

Koike, K.; Takayanagi, I.; Ichino, T.; Koshikawa, H.; Nagatomo, T. 1997: Beta3-adrenoceptors mediate relaxation of guinea pig taenia caecum by BRL37344A and BRL35135A. European Journal of Pharmacology 334(2-3): 217-221

Serrano, N.; Brock, H.W.; Maschat, F. 1997: beta3-tubulin is directly repressed by the engrailed protein in Drosophila. Development 124(13): 2527-2536

Atgié, C.; Tavernier, G.; D'Allaire, F.; Bengtsson, T.; Marti, L.; Carpéné, C.; Lafontan, M.; Bukowiecki, L.J.; Langin, D. 1996: Beta 3-adrenoceptor in guinea pig brown and white adipocytes: low expression and lack of function. American Journal of Physiology 271(6 Pt 2): R1729-R1738

Dell'Angelica, E.C.; Ooi, C.E.; Bonifacino, J.S. 1997: Beta3A-adaptin, a subunit of the adaptor-like complex AP-3. Journal of Biological Chemistry 272(24): 15078-15084

Dowling, J.; Yu, Q.C.; Fuchs, E. 1996: Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. Journal of Cell Biology 134(2): 559-572

McDonough, J.; Deneris, E. 1997: beta43': An enhancer displaying neural-restricted activity is located in the 3'-untranslated exon of the rat nicotinic acetylcholine receptor beta4 gene. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(7): 2273-2283

Raharivelomanna, P.; Faure, R.; Cambon, A.; Azzaro, M. 1993: Beta-Acoradienol, a sesquiterpene alcohol from Neocallitropsis pancheri. Phytochemistry 33(1): 235-236

Gimona, M.; Vandekerckhove, J.; Goethals, M.; Herzog, M.; Lando, Z.; Small, J.V. 1994: Beta-actin specific monoclonal antibody. Cell Motility and the Cytoskeleton 27(2): 108-116

Latham, V.M.; Kislauskis, E.H.; Singer, R.H.; Ross, A.F. 1994: Beta-actin mRNA localization is regulated by signal transduction mechanisms. Journal of Cell Biology 126(5): 1211-1219

Sharpless, K.; Biegel, D.; Yang, T.; Pachter, J.S. 1993: Beta-actin mRNA-binding proteins associated with the cytoskeletal framework. European Journal of Biochemistry 212(1): 217-225

Kislauskis, E.H.; Zhu, X.; Singer, R.H. 1997: beta-Actin messenger RNA localization and protein synthesis augment cell motility. Journal of Cell Biology 136(6): 1263-1270

Slotkin, T.A.; Lappi, S.E.; Seidler, F.J. 1995: Beta-adrenergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. Toxicology and Applied Pharmacology 133(2): 188-195

Park, P.G.; Merryman, J.; Orloff, M.; Schuller, H.M. 1995: Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Research 55(16): 3504-3508

Nielson, K.A.; Jensen, R.A. 1994: Beta-Adrenergic Receptor Antagonist Antihypertensive Medications Impair Arousal-Induced Modulation of Working Memory in Elderly Humans. Behavioral and Neural Biology 62(3): 190-200

Ming, M.; Wu, J.; Lachance, S.; Delalandre, A.; Carrière, S.; Chan, J.S. 1995: Beta-adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro. Hypertension 25(1): 105-109

Mio, T.; Adachi, Y.; Carnevali, S.; Romberger, D.J.; Spurzem, J.R.; Rennard, S.I. 1996: Beta-adrenergic agonists attenuate fibroblast-mediated contraction of released collagen gels. American Journal of Physiology 270(5 Part 1): L829-L835

Kume, H.; Hall, I.P.; Washabau, R.J.; Takagi, K.; Kotlikoff, M.I. 1994: Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. Journal of Clinical Investigation 93(1): 371-379

Port, J.D.; Huang, L.Y.; Malbon, C.C. 1992: Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. Journal of Biological Chemistry 267(33): 24103-24108

Rodefeld, M.D.; Beau, S.L.; Schuessler, R.B.; Boineau, J.P.; Saffitz, J.E. 1996: Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density. Journal of Cardiovascular Electrophysiology 7(11): 1039-1049

Hardouin, S.; Mansier, P.; Bertin, B.; Dakhly, T.; Swynghedauw, B.; Moalic, J.M. 1997: beta-Adrenergic and muscarinic receptor expression are regulated in opposite ways during senescence in rat left ventricle. Journal of Molecular and Cellular Cardiology 29(1): 309-319

Harris, G.C.; Hedaya, M.A.; Pan, W.J.; Kalivas, P. 1996: beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 14(3): 195-204

Lang, C.H. 1993: Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor. American Journal of Physiology 264(5 Pt 2): R984-R991

Mazzeo, R.S.; Brooks, G.A.; Butterfield, G.E.; Cymerman, A.; Roberts, A.C.; Selland, M.; Wolfel, E.E.; Reeves, J.T. 1994: Beta-adrenergic blockade does not prevent the lactate response to exercise after acclimatization to high altitude. Journal of Applied Physiology 76(2): 610-615

Lamont, L.S.; McCullough, A.J.; Kalhan, S.C. 1995: Beta-adrenergic blockade heightens the exercise-induced increase in leucine oxidation. American Journal of Physiology 268(5 Part 1): E910-E916

Segadal, J.; Lekven, J.; Hexeberg, E. 1993: Beta-adrenergic blockade improves uniformity of local contraction in the anterior wall of feline left ventricles. Clinical Physiology 13(2): 171-184

Groh, W.J.; Gibson, K.J.; McAnulty, J.H.; Maylie, J.G. 1995: Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Circulation 91(2): 262-264

Bousquet-Mélou, A.; Galitzky, J.; Carpéné, C.; Lafontan, M.; Berlan, M. 1994: Beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals. American Journal of Physiology 267(1 Part 2): R115-R123

Stratton, J.R.; Levy, W.C.; Schwartz, R.S.; Abrass, I.B.; Cerqueira, M.D. 1994: Beta-adrenergic effects on left ventricular filling: influence of aging and exercise training. Journal of Applied Physiology 77(6): 2522-2529

Llano, I.; Gerschenfeld, H.M. 1993: Beta-adrenergic enhancement of inhibitory synaptic activity in rat cerebellar stellate and Purkinje cells. Journal of Physiology 468: 201-224

Smith, T.K.; Ward, S.M.; Zhang, L.; Buxton, I.L.; Gerthoffer, W.T.; Sanders, K.M.; Keef, K.D. 1993: Beta-adrenergic inhibition of electrical and mechanical activity in canine colon: role of cAMP. American Journal of Physiology 264(4 Pt 1): G708-G717

Feldman, R.D. 1992: Beta-Adrenergic inhibition of sodium-potassium-chloride cotransport in lymphocytes. American Journal of Physiology 263(5 Part 1): C1015-C1020

Ireland, M.E.; Tran, K.; Mrock, L. 1993: Beta-adrenergic mechanisms affect cell division and differentiation in cultured chick lens epithelial cells. Experimental Eye Research 57(3): 325-333

Mills, C.L.; Hallett, M.B.; Mcpherson, M.A.; Dormer, R.L. 1993: Beta-Adrenergic mobilization of calcium from an intracellular store in rat submandibular acini. Biochemical Journal 293(3): 691-695

Huerta, M.; Trujillo, X.; Vásquez, C. 1997: Beta-Adrenergic modulation of Ba2+ currents and K+ contractures in frog slow skeletal muscle fibers. American Journal of Physiology 272(1 Part 1): C77-C81

Kopprasch, S.; Gatzweiler, A.; Graessler, J.; Schröder, H.E. 1997: Beta-adrenergic modulation of FMLP- and zymosan-induced intracellular and extracellular oxidant production by polymorphonuclear leukocytes. Molecular and Cellular Biochemistry 168(1-2): 133-139

Gould, T.J.; Adams, C.E.; Bickford, P.C. 1997: Beta-adrenergic modulation of GABAergic inhibition in the deep cerebellar nuclei of F344 rats. Neuropharmacology 36(1): 75-81

Charpentier, F.; Legato, M.J.; Steinberg, S.F.; Cohen, I.S.; Rosen, M.R. 1996: Beta-adrenergic modulation of Na-K pump activity in young and adult canine cardiac Purkinje fibers. American Journal of Physiology 271(2 Part 2): H706-H712

Roy, M.L.; Sontheimer, H. 1995: Beta-adrenergic modulation of glial inwardly rectifying potassium channels. Journal of Neurochemistry 64(4): 1576-1584

Mallick, H.; Manchanda, S.K.; Kumar, V.M. 1996: Beta-adrenergic modulation of male sexual behavior elicited from the medial preoptic area in rats. Behavioural Brain Research 74(1-2): 181-187

Ansari, M.A.; Gupta, G.; Baquer, N.Z. 1994: Beta-adrenergic modulation of rat brain insulin receptor activity in normal and hyperglycaemic conditions. Indian Journal of Experimental Biology 32(2): 92-94

Sellke, F.W.; Wang, S.Y.; Friedman, M.; Dai, H.B.; Harada, K.; Lopez, J.J.; Simons, M. 1995: Beta-adrenergic modulation of the collateral-dependent coronary microcirculation. Journal of Surgical Research 59(1): 185-190

Koumi, S.; Backer, C.L.; Arentzen, C.E.; Sato, R. 1995: Beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. Journal of Clinical Investigation 96(6): 2870-2881

Böhm, M.; Moll, M.; Schmid, B.; Paul, M.; Ganten, D.; Castellano, M.; Erdmann, E. 1994: Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension 24(6): 653-662

Cairns, S.P.; Dulhunty, A.F. 1993: Beta-adrenergic potentiation of E-C coupling increases force in rat skeletal muscle. Muscle and Nerve 16(12): 1317-1325

Bernhard, W.; Müller, B.; Von Wichert, P. 1994: beta-Adrenergic priming of rats in vivo modulates the effect of beta-agonist in vitro on surfactant phospholipid metabolism of isolated lungs. European Journal of Clinical Investigation 24(6): 393-399

Kwon, J.H.; Eves, E.M.; Farrell, S.; Segovia, J.; Tobin, A.J.; Wainer, B.H.; Downen, M. 1996: Beta-adrenergic receptor activation promotes process outgrowth in an embryonic rat basal forebrain cell line and in primary neurons. European Journal of Neuroscience 8(10): 2042-2055

Shams, G.; Romstedt, K.J.; Lust, L.A.; Clark, M.T.; Miller, D.D.; Feller, D.R. 1997: Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. General Pharmacology 28(2): 323-330

Little, K.Y.; Clark, T.B.; Ranc, J.; Duncan, G.E. 1993: Beta-adrenergic receptor binding in frontal cortex from suicide victims. Biological Psychiatry 34(9): 596-605

Little, K.Y.; Duncan, G.E.; Breese, G.R.; Stumpf, W.E. 1992: Beta-adrenergic receptor binding in human and rat hypothalamus. Biological Psychiatry 32(6): 512-522

Sutin, J.; Griffith, R. 1993: Beta-adrenergic receptor blockade suppresses glial scar formation. Experimental Neurology 120(2): 214-222

Brannan, S.K.; Miller, A.; Jones, D.J.; Kramer, G.L.; Petty, F. 1995: Beta-adrenergic receptor changes in learned helplessness may depend on stress and test parameters. Pharmacology Biochemistry and Behavior 51(2-3): 553-556

Drvota, V.; Wei, H.; Häggblad, J.; Carlsson, B.; Sylvén, C. 1995: Beta-adrenergic receptor function in cultured AT-1 cardiomyocytes. Biochemical and Biophysical Research Communications 207(1): 13-19

Hanson, A.S.; Linas, S.L. 1995: Beta-adrenergic receptor function in rat proximal tubule epithelial cells in culture. American Journal of Physiology 268(4 Pt 2): F553-F560

Ruiz-Gómez, A.; Mayor, F. 1997: Beta-adrenergic receptor kinase (GRK2) colocalizes with beta-adrenergic receptors during agonist-induced receptor internalization. Journal of Biological Chemistry 272(15): 9601-9604

Fukayama, S.; Kong, G.; Benovic, J.L.; Meurer, E.; Tashjian, A.H. 1997: Beta-adrenergic receptor kinase-1 acutely regulates PTH/PTHrP receptor signalling in human osteoblastlike cells. Cellular Signalling 9(6): 469-474

Chen, C.Y.; Dion, S.B.; Kim, C.M.; Benovic, J.L. 1993: Beta-adrenergic receptor kinase. Agonist-dependent receptor binding promotes kinase activation. Journal of Biological Chemistry 268(11): 7825-7831

Proll, M.A.; Clark, R.B.; Goka, T.J.; Barber, R.; Butcher, R.W. 1992: Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine. Molecular Pharmacology 42(1): 116-122

Slotkin, T.A.; Lau, C.; Seidler, F.J. 1994: Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicology and Applied Pharmacology 129(2): 223-234

Chou, R.C.; Stinson, M.W.; Noble, B.K.; Spengler, R.N. 1996: Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis. Journal of Neuroimmunology 67(1): 7-16

Yu, S.S.; Lefkowitz, R.J.; Hausdorff, W.P. 1993: Beta-adrenergic receptor sequestration. a potential mechanism of receptor resensitization. Journal of Biological Chemistry 268(1): 337-341

Sato, S.; Sato, N.; Kudej, R.K.; Uechi, M.; Asai, K.; Shen, Y.T.; Ishikawa, Y.; Vatner, S.F.; Vatner, D.E. 1997: Beta-adrenergic receptor signalling in stunned myocardium of conscious pigs. Journal of Molecular and Cellular Cardiology 29(5): 1387-1400

Strang, K.T.; Sweitzer, N.K.; Greaser, M.L.; Moss, R.L. 1994: Beta-adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circulation Research 74(3): 542-549

Principe, D.; Sanseverino, M.; Saunders, T.; Phillippe, M. 1997: Beta-adrenergic receptor subtype gene expression in timed-pregnant rat myometrium. American Journal of Obstetrics and Gynecology 176(2): 349-357

McNeel, R.L.; Mersmann, H.J. 1995: Beta-adrenergic receptor subtype transcripts in porcine adipose tissue. Journal of Animal Science 73(7): 1962-1971

Little, K.Y.; Kirkman, J.A.; Duncan, G.E. 1996: Beta-adrenergic receptor subtypes in human pineal gland. Journal of Pineal Research 20(1): 15-20

Pandey, S.C.; Ren, X.; Sagen, J.; Pandey, G.N. 1995: Beta-adrenergic receptor subtypes in stress-induced behavioral depression. Pharmacology Biochemistry and Behavior 51(2-3): 339-344

Takemura, H.; Hatta, S.; Yamada, K.; Ohshika, H. 1995: Beta-adrenergic receptor-mediated calcium mobilization in the human Jurkat T cell line. Life Sciences 56(18): 1443-1454

Mersmann, H.J.; McNeel, R.L.; Morkeberg, J.C.; Shparber, A.; Hachey, D.L. 1992: Beta-adrenergic receptor-mediated functions in porcine adipose tissue are not affected differently by saturated vs. unsaturated dietary fats. Journal of Nutrition 122(10): 1952-1959

Rosenberg, P.A.; Knowles, R.; Knowles, K.P.; Li, Y. 1994: Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(5 Part 2): 2953-2965

Stein, M.; Deegan, R.; He, H.; Wood, A.J. 1993: Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm. Clinical pharmacology and therapeutics 54(1): 58-64

Rajakumar, G.; Koller, M.M.; Scarpace, P.J. 1992: Beta-adrenergic receptors and salivary gland secretion during aging. Growth Development and Aging: Gda 56(4): 215-223

Kjaer, A.; Knigge, U.; Matzen, S.; Warberg, J. 1995: Beta-adrenergic receptors are involved in histamine-induced secretion of proopiomelanocortin-derived peptides and prolactin in rats. European Journal of Endocrinology 132(2): 223-228

Gorman, A.L.; Dunn, A.J. 1993: Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacology Biochemistry and Behavior 45(1): 1-7

Blauw, G.J.; Westendorp, R.G.; Simons, M.; Chang, P.C.; Frölich, M.; Meinders, A.E. 1995: Beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. British Journal of Clinical Pharmacology 40(5): 453-458

Brodde, O.E. 1996: Beta-adrenergic receptors in failing human myocardium. Basic Research in Cardiology 91(Suppl): 35-40

Akanbi, K.A.; Mersmann, H.J. 1996: Beta-adrenergic receptors in porcine adipocyte membranes: modification by animal age, depot site, and dietary protein deficiency. Journal of Animal Science 74(3): 551-561

Steinkraus, V.; Steinfath, M.; Stöve, L.; Körner, C.; Abeck, D.; Mensing, H. 1993: Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin. Archives of Dermatological Research 285(5): 300-304

Monastra, G.; Secchi, E.F. 1993: Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunology Letters 38(2): 127-130

Gøtzsche, L.B. 1993: Beta-adrenergic receptors, voltage-operated Ca(2+)-channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long-term low-dose amiodarone treatment. Acta Endocrinologica 129(4): 337-347

Bishopric, N.H.; Sato, B.; Webster, K.A. 1992: Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway. Journal of Biological Chemistry 267(29): 20932-20936

Charpentier, F.; Rosen, M.R. 1994: Beta-adrenergic regulation of action potentials and automaticity in young and adult canine purkinje fibers. American Journal of Physiology 266(6 Part 2): H2310-H2319

Kiss, E.; Edes, I.; Sato, Y.; Luo, W.; Liggett, S.B.; Kranias, E.G. 1997: beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts. American Journal of Physiology 272(2 Pt 2): H785-H790

Scott, L.; Prpic, V.; Capel, W.D.; Basavappa, S.; Mangel, A.W.; Gettys, T.W.; Liddle, R.A. 1996: Beta-adrenergic regulation of cholecystokinin secretion in STC-1 cells. American Journal of Physiology 270(2 Pt 1): G291-G297

Manger, T.M.; Pappas, C.A.; Koeppen, B.M. 1992: Beta-Adrenergic regulation of proton secretion by cultured outer medullary collecting duct cells. American Journal of Physiology 263(6 Part 2): F1011-F1019

Jikihara, H.; Handwerger, S.; Poisner, A.M. 1997: Beta-adrenergic regulation of renin expression in differentiated U-937 monocytic cells. Biochemical Pharmacology 53(12): 1883-1888

Hadjokas, N.E.; Crowley, J.J.; Bayer, C.R.; Nielson, C.P. 1995: Beta-adrenergic regulation of the eosinophil respiratory burst as detected by lucigenin-dependent luminescence. Journal of Allergy and Clinical Immunology 95(3): 735-741

López-Sañudo, S.; Arilla, E. 1994: Beta-adrenergic regulation of the somatostatinergic system in rat hippocampus. Neuroscience Letters 165(1-2): 27-32

Lukyanenko, V.; Katina, I.E.; Nasledov, G.A.; Terentyev, D.A. 1995: Beta-adrenergic regulation of voltage-dependent calcium currents in cultured skeletal myocytes of the frog Rana temporaria. General Physiology and Biophysics 14(6): 515-523

Blankesteijn, W.M.; Raat, N.J.; Willems, P.H.; Thien, T. 1996: Beta-Adrenergic relaxation in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto rats: the role of precontraction and intracellular Ca2+. Journal of Cardiovascular Pharmacology 27(1): 27-32

Feldman, R.D.; Freeman, D.J.; Bierbrier, G.S.; Anthony, S.E.; Brown, J.E. 1993: Beta-adrenergic responsiveness is regulated selectively in hypertension. Clinical pharmacology and therapeutics 54(6): 654-660

Kaartinen, J.M.; LaNoue, K.F.; Martin, L.F.; Vikman, H.L.; Ohisalo, J.J. 1995: Beta-adrenergic responsiveness of adenylate cyclase in human adipocyte plasma membranes in obesity and after massive weight reduction. Metabolism, Clinical and Experimental 44(10): 1288-1292

Blaak, E.E.; van Baak, M.A.; Kemerink, G.J.; Pakbiers, M.T.; Heidendal, G.A.; Saris, W.H. 1995: Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism, Clinical and Experimental 44(2): 183-187

Dehaye, J.P.; Valdez, I.H.; Turner, R.J. 1993: Beta-adrenergic stimulation and cAMP mobilize Ca2+ from an IP3-insensitive pool in rat submandibular granular ducts. American Journal of Physiology 265(5 Pt 1): C1356-C1362

Hori, M.; Sato, H.; Kitakaze, M.; Iwai, K.; Takeda, H.; Inoue, M.; Kamada, T. 1994: Beta-adrenergic stimulation disassembles microtubules in neonatal rat cultured cardiomyocytes through intracellular Ca2+ overload. Circulation Research 75(2): 324-334

Ishizuka, N.; Berlin, J.R. 1993: Beta-Adrenergic stimulation does not regulate sodium pump function in voltage-clamped ventricular myocyte of the rat heart. Pfluegers Archiv European Journal of Physiology 424(3-4): 361-363

Barnett, C.C.; Moore, E.E.; Partrick, D.A.; Silliman, C.C. 1997: Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release. Journal of Surgical Research 70(2): 166-170

Nixdorff, U.; de Mey, C.; Belz, G.G.; Erbel, R.; Simon, H.; Butzer, R.; Schroeter, V.; Meyer, J. 1997: Beta-adrenergic stimulation enhances left ventricular diastolic performance in normal subjects. Journal of Cardiovascular Pharmacology 29(4): 476-484

Wang, Y.G.; Lipsius, S.L. 1995: beta-Adrenergic stimulation induces acetylcholine to activate ATP-sensitive K+ current in cat atrial myocytes. Circulation Research 77(3): 565-574

Pianet, I.; Canioni, P.; Labouesse, J.; Merle, M. 1992: Beta-adrenergic stimulation of C6 glioma cells: effects of cAMP overproduction on cellular metabolites. a multinuclear NMR study. European Journal of Biochemistry 209(2): 707-715

Wassermann, G.F.; Ludwig, M.S.; Barreto, K.P. 1996: Beta-Adrenergic stimulation of amino acid transport in Sertoli cell-enriched testes of rats is independent of its action on protein synthesis. Medical Science Research 24(3): 149-151

Boutillier, A.L.; Barthel, F.; Roberts, J.L.; Loeffler, J.P. 1992: Beta-adrenergic stimulation of cFOS via protein kinase A is mediated by cAMP regulatory element binding protein (CREB)-dependent and tissue-specific CREB-independent mechanisms in corticotrope cells. Journal of Biological Chemistry 267(33): 23520-23526

Long, C.S.; Hartogensis, W.E.; Simpson, P.C. 1993: Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. Journal of Molecular and Cellular Cardiology 25(8): 915-925

Blaak, E.E.; Van Baak, M.A.; Kemerink, G.J.; Pakbiers, M.T.; Heidendal, G.A.; Saris, W.H. 1994: Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. American Journal of Physiology 267(2 Pt 1): E306-E315

Burýsek, L.; Houstek, J. 1997: beta-Adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes. Febs Letters 411(1): 83-86

Blaak, E.E.; Van Baak, M.A.; Kemerink, G.J.; Pakbiers, M.T.; Heidendal, G.A.; Saris, W.H. 1994: beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. American Journal of Physiology 267(2 Pt 1): E316-E322

Do, K.Q.; Benz, B.; Sorg, O.; Pellerin, L.; Magistretti, P.J. 1997: beta-Adrenergic stimulation promotes homocysteic acid release from astrocyte cultures: evidence for a role of astrocytes in the modulation of synaptic transmission. Journal of Neurochemistry 68(6): 2386-2394

Cloues, R.K.; Tavalin, S.J.; Marrion, N.V. 1997: Beta-adrenergic stimulation selectively inhibits long-lasting L-type calcium channel facilitation in hippocampal pyramidal neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(17): 6493-6503

Somer, H.; Mäki, T.; Härkönen, M. 1992: Beta-adrenergic system in myotonic dystrophy. Journal of the Neurological Sciences 111(2): 214-217

Storey, J.M.; Storey, K.B. 1996: Beta-Adrenergic, hormonal, and nervous influences on cryoprotectant synthesis by liver of the free-tolerant wood frog Rana sylvatica. Cryobiology 33(1): 186-195

Dziki, A.J.; Lynch, W.H.; Ramsey, C.B.; Law, W.R. 1993: Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock. Circulatory Shock 39(1): 29-38

Blaak, E.E.; van Baak, M.A.; Kester, A.D.; Saris, W.H. 1995: Beta-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss. Metabolism, Clinical and Experimental 44(4): 520-524

Cairns, S.P.; Dulhunty, A.F. 1994: Beta-adrenoceptor activation shows high-frequency fatigue in skeletal muscle fibers of the rat. American Journal of Physiology 266(5 Pt 1): C1204-C1209

Downing, G.J.; Poisner, R.; Poisner, A.M. 1994: Beta-adrenoceptor activation stimulates, and phosphodiesterase inhibition potentiates, placental prorenin synthesis and release. Journal of Clinical Endocrinology and Metabolism 78(1): 41-47

Graves, J.; Poston, L. 1993: Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. British Journal of Pharmacology 108(3): 631-637

Peters, M.J.; Adcock, I.M.; Brown, C.R.; Barnes, P.J. 1995: Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. European Journal of Pharmacology 289(2): 275-281

Amos, G.; Kerr, D.; Sernia, C.; Brown, L. 1994: Beta-adrenoceptor antagonism and the hyperthyroid rat heart. Journal of Cardiovascular Pharmacology 24(2): 336-343

Van Baak, M.A.; de Haan, A.; Saris, W.H.; van Kordelaar, E.; Kuipers, H.; van der Vusse, G.J. 1995: Beta-adrenoceptor blockade and skeletal muscle energy metabolism during endurance exercise. Journal of Applied Physiology 78(1): 307-313

Herxheimer, A. 1994: Beta-Adrenoceptor blockers in atrial fibrillation: The importance of partial agonist activity. British Journal of Clinical Pharmacology 37(6): 613

Nwosu, U.C.; Rice, P.J. 1995: Beta-adrenoceptor changes in mononuclear leukocytes during pregnancy. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 209(2): 157-162

Giannuzzi, C.E.; Seidler, F.J.; Slotkin, T.A. 1995: Beta-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Research 694(1-2): 271-278

Vatner, D.E.; Sato, N.; Ishikawa, Y.; Kiuchi, K.; Shannon, R.P.; Vatner, S.F. 1996: Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure. Clinical and Experimental Pharmacology and Physiology 23(8): 688-692

Michel, M.C.; Feth, F.; Sundermann, M.; Rascher, W.; Brodde, O.E. 1993: Beta-Adrenoceptor desensitization in SK-N-MC cells, a human cell line containing a homogeneous population of beta-1-adrenoceptors. Journal of Autonomic Pharmacology 13(6): 425-438

Delehanty, J.M.; Himura, Y.; Elam, H.; Hood, W.B.; Liang, C.S. 1994: Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. American Journal of Physiology 266(3 Part 2): H930-H935

Zoukos, Y.; Thomaides, T.; Pavitt, D.V.; Cuzner, M.L.; Mathias, C.J. 1993: Beta-adrenoceptor expression on circulating mononuclear cells of idiopathic Parkinson's disease and autonomic failure patients before and after reduction of central sympathetic outflow by clonidine. Neurology 43(6): 1181-1187

Davies, C.H.; Ferrara, N.; Harding, S.E. 1996: Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovascular Research 31(1): 152-156

Eikvar, L.; Bjørnerheim, R.; Attramadal, H.; Hansson, V. 1993: Beta-adrenoceptor mediated responses and subtypes of beta-adrenoceptors in cultured rat Sertoli cells. Journal of Steroid Biochemistry and Molecular Biology 44(1): 85-91

Kaura, D.; Takeda, N.; Sethi, R.; Wang, X.; Nagano, M.; Dhalla, N.S. 1996: Beta-adrenoceptor mediated signal transduction in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters. Molecular and Cellular Biochemistry 157(1-2): 191-196

Song, Y.; Simard, J.M. 1995: Beta-Adrenoceptor stimulation activates large-conductance Ca2+-activated K+ channels in smooth muscle cells from basilar artery of guinea pig. Pflugers Archiv: European Journal of Physiology 430(6): 984-993

Nasa, Y.; Yabe, K.; Takeo, S. 1997: Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts. Journal of Cardiovascular Pharmacology 29(4): 436-443

Cerbai, E.; Guerra, L.; Varani, K.; Barbieri, M.; Borea, P.A.; Mugelli, A. 1995: Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. British Journal of Pharmacology 116(2): 1835-1842

Wheeldon, N.M.; McDevitt, D.G.; McFarlane, L.C.; Lipworth, B.J. 1994: Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man. Clinical Science 86(3): 331-337

Manier, D.H.; Eiring, A.; Shelton, R.C.; Sulser, F. 1996: Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 15(6): 555-561

Persad, S.; Takeda, S.; Panagia, V.; Dhalla, N.S. 1997: Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals. Journal of Molecular and Cellular Cardiology 29(2): 545-558

Rousell, J.; Haddad, E.B.; Mak, J.C.; Webb, B.L.; Giembycz, M.A.; Barnes, P.J. 1996: Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C. Molecular Pharmacology 49(4): 629-635

Brunn, G.; Wessler, I.; Anderson, G.P.; Maclagan, J.; Racké, K. 1994: Beta-adrenoceptor-mediated facilitation of endogenous noradrenaline release from rat isolated trachea. Naunyn-Schmiedeberg's Archives of Pharmacology 350(5): 459-463

Von der Weid, P.Y.; Van Helden, D.F. 1996: Beta-adrenoceptor-mediated hyperpolarization in lymphatic smooth muscle of guinea pig mesentery. American Journal of Physiology 270(5 Part 2): H1687-H1695

Ming, M.; Chan, W.; Wang, T.T.; Roberts, K.D.; Bouvier, M.; Lachance, S.; Carrière, S.; Chan, J.S. 1996: Beta-Adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells. Kidney International 50(1): 94-101

Lu, Z.; Qu, P.; Xu, K.; Han, C. 1995: beta-Adrenoceptors in endothelium of rabbit coronary artery and alteration in atherosclerosis. Biological Signals 4(3): 150-159

Beenen, O.H.; Batink, H.D.; Pfaffendorf, M.; van Zwieten, P.A. 1997: Beta-andrenoceptors in the hearts of diabetic-hypertensive rats: radioligand binding and functional experiments. Blood Pressure 6(1): 44-51

Manna, F.; Chimenti, F.; Bolasco, A.; Lena, R.; Filippelli, A.; Falciani, M.; Fontana, M. 1996: Beta-adrenoreceptor blocking heterocyclic oximes and ethers. Farmaco 51(11): 699-706

Gamperl, A.K.; Wilkinson, M.; Boutilier, R.G. 1994: Beta-adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterization, quantification, and effects of repeated catecholamine exposure. General and Comparative Endocrinology 95(2): 259-272

Das, S.K.; Mukherjee, S.; Banerjee, D.K. 1994: Beta-adrenoreceptors of multiple affinities in a clonal capillary endothelial cell line and its functional implication. Molecular and Cellular Biochemistry 140(1): 49-54

Zocchi, L.; Agostoni, E.; Cremaschi, D. 1995: Beta-agonist activation of an amiloride-insensitive transport mechanism in rabbit pleura. Respiration Physiology 100(1): 7-13

Nakahari, T.; Marunaka, Y. 1997: Beta-agonist-induced activation of Na+ absorption and KCl release in rat fetal distal lung epithelium: a study of cell volume regulation. Experimental Physiology 82(3): 521-536

Pertseva, M.N.; Kuznetzova, L.A.; Plesneva, S.A.; Grishin, A.V.; Panchenko, M.P. 1992: Beta-agonist-induced inhibitory-guanine-nucleotide-binding regulatory protein coupling to adenylate cyclase in mollusc Anodonta cygnea foot muscle sarcolemma. European Journal of Biochemistry 210(1): 279-286

Schilt, R.; Hooijerink, H.; Courtheyn, D.; Boenke, A. 1996: Beta-agonists in animal feed. I: First intercomparison of methods of analysis for clenbuterol in animal feed materials. Food Additives and Contaminants 13(5): 477-492

Courtheyn, D.; Moermans, R.; Schilt, R.; Boenke, A. 1996: Beta-agonists in animal feed. II: Optimization of the extraction. Food Additives and Contaminants 13(5): 493-509

Leyssens, L.; Courtheyn, D.; Schilt, R.; Berthoz, Y.; Moermans, R.; Boenke, A. 1996: beta-agonists in animal feed. III: Optimization of the clean-up and the end-determination step. Food Additives and Contaminants 13(7): 795-810

Leyssens, L.; Noben, J.P.; Courtheyn, D.; Boenke, A. 1996: Beta-agonists in animal feed. IV: Intercomparison study of a candidate reference confirmatory method. Food Additives and Contaminants 13(8): 883-895

Fernandez, I. 1996: Beta-Alanine binds to uptake sites when using physiological concentrations of sodium. Medical Science Research 24(9): 601-602

Pavone, V.; Lombardi, A.; Saviano, M.; Di Blasio, B.; Nastri, F.; Fattorusso, R.; Maglio, O.; Isernia, C. 1994: Beta-alanine containing cyclic peptides with predetermined turned structure. V. Biopolymers 34(11): 1505-1515

Yamaguchi, M. 1995: Beta-Alanyl-L-histidinato zinc and bone resorption. General Pharmacology 26(6): 1179-1183

Segawa, Y.; Tsuzuike, N.; Itokazu, Y.; Tagashira, E.; Yamaguchi, M. 1992: Beta-Alanyl-L-histidinato zinc prevents hydrocortisone-induced disorder of bone metabolism in rats. Research in Experimental Medicine. Zeitschrift für die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie 192(5): 317-322

Katerinopoulos, H.E.; Tagmatarchis, N.; Zaponakis, G.; Kefalakis, N.; Kordatos, K.; Spyrakis, M.; Thermos, K. 1995: Beta-Alkoxy-substituted phenethylamines: A family of compounds potentially active at the dopamine and alpha-adrenergic receptors. European Journal of Medicinal Chemistry 30(12): 949-954

Benedetti, E.; Iacovino, R.; Pedone, C.; Rossi, F.; Saviano, M.; Isernia, C.; Montesarchio, D.; De-Napoli, L.; Piccialli, G. 1997: Beta-Amino acid residues: Conformational characterization of an N- and C-protected homo-beta-(S)-leucine. Letters in Peptide Science 4(3): 129-134

Cohen, Y..; Niderman, T..; Mosinger, E..; Fluhr, R.. 1994: Beta]-Aminobutyric Acid Induces the Accumulation of Pathogenesis-Related Proteins in Tomato (Lycopersicon esculentum L.) Plants and Resistance to Late Blight Infection Caused by Phytophthora infestans. Plant Physiology 104(1): 59-66

Nandi, S.D.s, G.S.n-Mandi, S. 1995: Beta-Amylase activity as an index for germination potential in rice. Annals of botany 75(5): 463-467

Swamy, M.V.; Ram, M.S.; Seenayya, G. 1994: Beta-Amylase from Clostridium thermocellum SS8: A thermophilic, anaerobic, cellulolytic bacterium. Letters in Applied Microbiology 18(6): 301-304

Doyen, C.; Lauriere, C. 1992: Beta-Amylases in germinating maize grains: Purification, partial characterization and antigenic relationships. Phytochemistry 31(11): 3697-3702

Armstrong, R.A. 1996: Beta-Amyloid (A-beta) deposits and blood vessels: Laminar distribution in the frontal cortex of patients with Alzheimer's disease. Neuroscience Research Communications 18(1): 19-28

Sigurdsson, E.M.; Hejna, M.J.; Lee, J.M.; Lorens, S.A. 1995: Beta-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: behavioral, neurochemical and histological effects. Behavioural Brain Research 72(1-2): 141-156

Arispe, N.; Pollard, H.B.; Rojas, E. 1994: Beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Molecular and Cellular Biochemistry 140(2): 119-125

Takenouchi, T.; Munekata, E. 1995: beta-Amyloid peptide, substance P, and SEC receptor ligand activate cytoplasmic Ca2+ in neutrophil-like HL-60 cells: effect of chemotactic peptide antagonist BocMLF. Peptides 16(6): 1019-1024

Griffith, L.S.; Mathes, M.; Schmitz, B. 1995: Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. Journal of Neuroscience Research 41(2): 270-278

Cummings, B.J.; Head, E.; Afagh, A.J.; Milgram, N.W.; Cotman, C.W. 1996: Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiology of Learning and Memory 66(1): 11-23

Cummings, B.J.; Su, J.H.; Cotman, C.W.; White, R.; Russell, M.J. 1993: Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiology of Aging 14(6): 547-560

Shea, T.B.; Prabhakar, S.; Ekinci, F.J. 1997: Beta-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: differential involvement of the calpain/protein kinase C system. Journal of Neuroscience Research 49(6): 759-768

Cotman, C.W.; Tenner, A.J.; Cummings, B.J. 1996: beta-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiology of Aging 17(5): 723-731

Wisniewski, H.M.; Wegiel, J. 1994: Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathologica 87(3): 233-241

Galdzicki, Z.; Fukuyama, R.; Wadhwani, K.C.; Rapoport, S.I.; Ehrenstein, G. 1994: Beta-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Research 646(2): 332-336

Pike, C.J.; Ramezan-Arab, N.; Miller, S.; Cotman, C.W. 1996: beta-Amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes. Experimental Neurology 139(1): 167-171

Li, Y.P.; Bushnell, A.F.; Lee, C.M.; Perlmutter, L.S.; Wong, S.K. 1996: Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Research 738(2): 196-204

Busciglio, J.; Yeh, J.; Yankner, B.A. 1993: beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. Journal of Neurochemistry 61(4): 1565-1568

Lorenzo, A.; Yankner, B.A. 1994: Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proceedings of the National Academy of Sciences of the United States of America 91(25): 12243-12247

Haass, C.; Hung, A.Y.; Schlossmacher, M.G.; Teplow, D.B.; Selkoe, D.J. 1993: beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. Journal of Biological Chemistry 268(5): 3021-3024

Crino, P.B.; Martin, J.A.; Hill, W.D.; Greenberg, B.; Lee, V.M.; Trojanowski, J.Q. 1995: Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome. Annals of Otology Rhinology and Laryngology 104(8): 655-661

Good, T.A.; Smith, D.O.; Murphy, R.M. 1996: Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophysical Journal 70(1): 296-304

Müller, W.E.; Koch, S.; Eckert, A.; Hartmann, H.; Scheuer, K. 1995: beta-Amyloid peptide decreases membrane fluidity. Brain Research 674(1): 133-136

Arias, C.; Arrieta, I.; Tapia, R. 1995: beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. Journal of Neuroscience Research 41(4): 561-566

Butterfield, D.A.; Hensley, K.; Harris, M.; Mattson, M.; Carney, J. 1994: beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochemical and Biophysical Research Communications 200(2): 710-715

May, P.C.; Gitter, B.D.; Waters, D.C.; Simmons, L.K.; Becker, G.W.; Small, J.S.; Robison, P.M. 1992: Beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiology of Aging 13(5): 605-607

Salinero, O.; Moreno-Flores, M.T.; Ceballos, M.L.; Wandosell, F. 1997: Beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. Journal of Neuroscience Research 47(2): 216-223

Naidu, A.; Quon, D.; Cordell, B. 1995: beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. Journal of Biological Chemistry 270(3): 1369-1374

Bitting, L.; Naidu, A.; Cordell, B.; Murphy, G.M. 1996: Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. Journal of Biological Chemistry 271(27): 16084-16089

Harris, M.E.; Carney, J.M.; Cole, P.S.; Hensley, K.; Howard, B.J.; Martin, L.; Bummer, P.; Wang, Y.; Pedigo, N.W.; Butterfield, D.A. 1995: beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport 6(14): 1875-1879

Korotzer, A.R.; Pike, C.J.; Cotman, C.W. 1993: beta-Amyloid peptides induce degeneration of cultured rat microglia. Brain Research 624(1-2): 121-125

Cadman, E.D.; Puttfarcken, P.S. 1997: Beta-amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro. Experimental Neurology 146(2): 388-394

Fukuyama, R.; Wadhwani, K.C.; Galdzicki, Z.; Rapoport, S.I.; Ehrenstein, G. 1994: Beta-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease. Brain Research 667(2): 269-272

Askanas, V.; Alvarez, R.B.; Engel, W.K. 1993: beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Annals of Neurology 34(4): 551-560

Willoughby, D.A.; Rozovsky, I.; Lo, A.C.; Finch, C.E. 1995: Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain. Journal of Molecular Neuroscience: Mn 6(4): 257-276

Calzada, B.; Cabal, A.; Naves, F.J.; del Valle, M.E.; Represa, J.J.; Vega, J.A. 1994: beta-Amyloid precursor protein (APP)-like immunoreactivity in the human sympathetic ganglia. Mechanisms of Ageing and Development 76(2-3): 135-144

Zhang, M.; Olsson, Y. 1996: Beta-amyloid precursor protein accumulates in axons around hematogenous metastases of the human brain: immunohistochemical observations. Clinical Neuropathology 15(2): 74-78

Kibbey, M.C.; Jucker, M.; Weeks, B.S.; Neve, R.L.; Van Nostrand, W.E.; Kleinman, H.K. 1993: beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proceedings of the National Academy of Sciences of the United States of America 90(21): 10150-10153

Hajimohammadreza, I.; Anderson, V.E.; Cavanagh, J.B.; Seville, M.P.; Nolan, C.C.; Anderton, B.H.; Leigh, P.N. 1994: beta-Amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin. Brain Research 640(1-2): 25-32

Levy, E.; Amorim, A.; Frangione, B.; Walker, L.C. 1995: beta-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy. Neurobiology of Aging 16(5): 805-808

Vega, J.A.; Diaz-Trelles, R.; Haro, J.J.; del Valle, M.E.; Naves, F.J.; Fernández-Sánchez, M.T. 1995: Beta-amyloid precursor protein in human digital skin. Neuroscience Letters 192(2): 132-136

Löffler, J.; Huber, G. 1992: Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development. Journal of Neurochemistry 59(4): 1316-1324

Procter, A.W.; Francis, P.T.; Holmes, C.; Webster, M.T.; Qume, M.; Stratmann, G.C.; Doshi, R.; Mann, D.M.; Harrison, P.J.; Pearson, R.C. 1994: Beta-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects. Acta Neuropathologica 88(6): 545-552

Palacios, G.; Palacios, J.M.; Mengod, G.; Frey, P. 1992: Beta-amyloid precursor protein localization in the Golgi apparatus in neurons and oligodendrocytes. An immunocytochemical structural and ultrastructural study in normal and axotomized neurons. Brain Research. Molecular Brain Research 15(3-4): 195-206

Sarkozi, E.; Askanas, V.; Johnson, S.A.; Engel, W.K.; Alvarez, R.B. 1993: Beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport 4(6): 815-818

Zheng, H.; Jiang, M.; Trumbauer, M.E.; Sirinathsinghji, D.J.; Hopkins, R.; Smith, D.W.; Heavens, R.P.; Dawson, G.R.; Boyce, S.; Conner, M.W.; Stevens, K.A.; Slunt, H.H.; Sisoda, S.S.; Chen, H.Y.; Van der Ploeg, L.H. 1995: Beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81(4): 525-531

Tischer, E.; Cordell, B. 1996: Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage. Journal of Biological Chemistry 271(36): 21914-21919

Hartmann, H.; Eckert, A.; Müller, W.E. 1993: Beta-Amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochemical and Biophysical Research Communications 194(3): 1216-1220

Eckert, A.; Hartmann, H.; Müller, W.E. 1993: beta-Amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. Febs Letters 330(1): 49-52

Frucht, S.J.; Koo, E.H. 1993: beta-Amyloid protein is higher in Alzheimer's disease brains: description of a quantitative biochemical assay. Journal of Neuropathology and Experimental Neurology 52(6): 640-647

Oyama, F.; Shimada, H.; Oyama, R.; Titani, K.; Ihara, Y. 1993: Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain. Journal of Neurochemistry 60(5): 1658-1664

Robertson, T.A.; Dutton, N.S.; Martins, R.N.; Roses, A.D.; Kakulas, B.A.; Papadimitriou, J.M. 1997: Beta-amyloid protein-containing inclusions in skeletal muscle of apolipoprotein-E-deficient mice. American Journal of Pathology 150(2): 417-427

Ii, M.; Sunamoto, M.; Ohnishi, K.; Ichimori, Y. 1996: beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Research 720(1-2): 93-100

Nitta, A.; Itoh, A.; Hasegawa, T.; Nabeshima, T. 1994: beta-Amyloid protein-induced Alzheimer's disease animal model. Neuroscience Letters 170(1): 63-66

Wu, J.; Anwyl, R.; Rowan, M.J. 1995: Beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport 6(17): 2409-2413

Bruce, A.J.; Malfroy, B.; Baudry, M. 1996: Beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proceedings of the National Academy of Sciences of the United States of America 93(6): 2312-2316

Meda, L.; Bonaiuto, C.; Szendrei, G.I.; Ceska, M.; Rossi, F.; Cassatella, M.A. 1995: beta-Amyloid(25-35) induces the production of interleukin-8 from human monocytes. Journal of Neuroimmunology 59(1-2): 29-33

Haas, C.; Hung, A.Y.; Citron, M.; Teplow, D.B.; Selkoe, D.J. 1995: beta-Amyloid, protein processing and Alzheimer's disease. Arzneimittel-Forschung 45(3a): 398-402

Le, W.; Xie, W.J.; Nyormoi, O.; Ho, B.K.; Smith, R.G.; Appel, S.H. 1995: beta-Amyloid1-40 increases expression of beta-amyloid precursor protein in neuronal hybrid cells. Journal of Neurochemistry 65(5): 2373-2376

Hertel, C.; Hauser, N.; Schubenel, R.; Seilheimer, B.; Kemp, J.A. 1996: Beta-amyloid-induced cell toxicity: enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-dependent cell death. Journal of Neurochemistry 67(1): 272-276

Pike, C.J.; Cummings, B.J.; Monzavi, R.; Cotman, C.W. 1994: Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63(2): 517-531

Le, W.D.; Xie, W.J.; Kong, R.; Appel, S.H. 1997: Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. Journal of Neurochemistry 69(3): 978-985

Manelli, A.M.; Puttfarcken, P.S. 1995: beta-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Research Bulletin 38(6): 569-576

Kar, S.; Seto, D.; Gaudreau, P.; Quirion, R. 1996: Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(3): 1034-1040

Gaydou, E.M.; Faure, R.; Wollenweber, E. 1996: Beta-Amyrin acetate epoxide from Canarina canariensis. Phytochemistry 42(4): 1115-1118

Gradelet, S.; Leclerc, J.; Siess, M.H.; Astorg, P.O. 1996: Beta-Apo-8'-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 26(9): 909-919

Ohguro, H.; Chiba, S.; Igarashi, Y.; Matsumoto, H.; Akino, T.; Palczewski, K. 1993: Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proceedings of the National Academy of Sciences of the United States of America 90(8): 3241-3245

Raharivelomanana, P.; Cambon, A.; Azzaro, M.; Bianchini, J.P.; Faure, R. 1993: Beta-Bisabolenol and beta-bisabolenal, two new bisabolene sesquiterpenes from Neocallitropsis pancheri. Journal of Natural Products 56(2): 272-274

Borst, M.M.; Marquetant, R.; Kübler, W.; Strasser, R.H. 1997: Beta-blockade reduces effects of adenosine and carbachol by transregulation of inhibitory receptors and Gi proteins. American Journal of Physiology 272(4 Part 2): H1672-H1679

Kantola, I.; Tarssanen, L.; Scheinin, M.; Ruskoaho, H.; Viinamäki, O.; Kaila, T. 1996: Beta-blockade, atrial natriuretic peptide and exercise. International Journal of Clinical Pharmacology and Therapeutics 34(1): 12-16

Gurwitz, J.H.; Goldberg, R.J.; Chen, Z.; Gore, J.M.; Alpert, J.S. 1992: Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. American Journal of Medicine 93(6): 605-610

Love, J.N. 1994: Beta-blocker toxicity: a clinical diagnosis. American Journal of Emergency Medicine 12(3): 356-357

Hash, T.W.; Prisant, L.M. 1997: Beta-blocker use in systolic heart failure and dilated cardiomyopathy. Journal of Clinical Pharmacology 37(1): 7-19

Kendall, M.J.; Lynch, K.P.; Hjalmarson, A.; Kjekshus, J. 1995: Beta-blockers and sudden cardiac death. Annals of Internal Medicine 123(5): 358-367

Goldstein, S. 1996: Beta-blockers in hypertensive and coronary heart disease. Archives of Internal Medicine 156(12): 1267-1276

Okuhira, M.; Nakazawa, M.; Kameda, H.; Hara, K.; Kawada, T.; Imai, S. 1993: Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Archives Internationales de Pharmacodynamie et de Therapie 323: 5-15

Boriani, G.; Capucci, A.; Strocchi, E.; Marchesini, B.; Santarelli, A.; Biffi, M.; Magnani, B. 1993: Beta-Blocking properties of propafenone in extensive oxidisers: A study on heart rate behaviour during Holter monitoring. Drug Investigation 6(1): 25-32

Qiao, J.; Wang, Z.Y.; Link, H. 1994: beta-Bungarotoxin binding protein is immunogenic but lacks myasthenogenicity in rats. Journal of the Neurological Sciences 121(2): 190-193

Ueno, E.; Rosenberg, P. 1995: Beta-Bungarotoxin blocks phorbol ester-stimulated phosphorylation of MARCKS, GAP-43 and synapsin I in rat brain synaptosomes. Toxicon: Official Journal of the International Society on Toxinology 33(6): 747-762

Pirker, W.; Asenbaum, S.; Kasper, S.; Walter, H.; Angelberger, P.; Koch, G.; Pozzera, A.; Deecke, L.; Podreka, I.; Brücke, T. 1995: beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. Journal of Neural Transmission. General Section 100(3): 247-256

Pepperkok, R.; Scheel, J.; Horstmann, H.; Hauri, H.P.; Griffiths, G.; Kreis, T.E. 1993: Beta-COP is essential for biosynthetic membrane transport from the endoplasmic reticulum to the Golgi complex in vivo. Cell 74(1): 71-82

Peter, F.; Plutner, H.; Zhu, H.; Kreis, T.E.; Balch, W.E. 1993: Beta-COP is essential for transport of protein from the endoplasmic reticulum to the Golgi in vitro. Journal of Cell Biology 122(6): 1155-1167

Oprins, A.; Duden, R.; Kreis, T.E.; Geuze, H.J.; Slot, J.W. 1993: Beta-COP localizes mainly to the cis-Golgi side in exocrine pancreas. Journal of Cell Biology 121(1): 49-59

Blech, S.; Budzikiewicz, H.; Dill, D. 1994: Beta-Carboline alkaloids from Ribes nigrum L. Zeitschrift fuer Naturforschung Section C Biosciences 49(9-10): 540-544

Bracher, F.; Hildebrand, D. 1993: Beta-Carboline alkaloids: II. Tributyl(1-ethoxyvinyl)stannane as a C-2-building block in the synthesis of beta-carboline alkaloids. Liebigs Annalen der Chemie 1993(8): 837-839

Stevenson, A.; Wingrove, P.B.; Whiting, P.J.; Wafford, K.A. 1995: Beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Molecular Pharmacology 48(6): 965-969

Settimj, G.; Del-Giudice, M.R.; Ferretti, R.; Cotichini, V.; Bruni, G.; Romeo, M.R. 1995: Beta-Carbolines as inverse agonistic benzodiazepine receptor ligands. 2. Synthesis and in vitro and in vivo binding of some new 6-amino- and 6-fluoro-beta-carboline-3-carboxylates. European Journal of Medicinal Chemistry 30(3): 245-251

Larsen, L.K.; Moore, R.E.; Patterson, G.M. 1994: beta-Carbolines from the blue-green alga Dichothrix baueriana. Journal of Natural Products 57(3): 419-421

Spies, C.D.; Rommelspacher, H.; Schnapper, C.; Müller, C.; Marks, C.; Berger, G.; Conrad, C.; Blum, S.; Specht, M.; Hannemann, L. 1995: Beta-carbolines in chronic alcoholics undergoing elective tumor resection. Alcoholism Clinical and Experimental Research 19(4): 969-976

Taub, M.E.; Larsen, B.D.; Steffansen, B.; Frokjaer, S. 1997: Beta-Carboxylic acid esterified D-Asp-Ala retains a high affinity for the oligopeptide transporter in Caco-2 monolayers. International Journal of Pharmaceutics (Amsterdam) 146(2): 205-212

Van Vliet, T.; van Vlissingen, M.F.; van Schaik, F.; van den Berg, H. 1996: Beta-Carotene absorption and cleavage in rats is affected by the vitamin a concentration of the diet. Journal of Nutrition 126(2): 499-508

Pellett, L.J.; Andersen, H.J.; Chen, H.; Tappel, A.L. 1994: Beta-Carotene alters vitamin E protection against heme protein oxidation and lipid peroxidation in chicken liver slices. Journal of Nutritional Biochemistry 5(10): 479-484

Bitterman, N.; Melamed, Y.; Ben-Amotz, A. 1994: Beta-carotene and CNS oxygen toxicity in rats. Journal of Applied Physiology 76(3): 1073-1076

Sun, J.; Giraud, D.W.; Moxley, R.A.; Driskell, J.A. 1997: Beta-Carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 67(3): 155-163

Martin, K.R.; Failla, M.L.; Smith, J.C. 1996: Beta-carotene and lutein protect HepG2 human liver cells against oxidant-induced damage. Journal of Nutrition 126(9): 2098-2106

Potter, J.D. 1997: beta-Carotene and the role of intervention studies. Cancer Letters 114(1-2): 329-331

Atreja, P.P.; Chhabra, A.; Kaur, H. 1992: Beta-Carotene and vitamin A levels in blood serum of pre-ruminant animals. Indian Journal of Animal Nutrition 9(1): 30-34

Nakagawa, K.; Fujimoto, K.; Miyazawa, T. 1996: beta-carotene as a high-potency antioxidant to prevent the formation of phospholipid hydroperoxides in red blood cells of mice. Biochimica et Biophysica Acta 1299(1): 110-116

Ozhogina, O.A.; Kasaikina, O.T. 1995: Beta-carotene as an interceptor of free radicals. Free Radical Biology and Medicine 19(5): 575-581

Gottlieb, K.; Zarling, E.J.; Mobarhan, S.; Bowen, P.; Sugerman, S. 1993: Beta-carotene decreases markers of lipid peroxidation in healthy volunteers. Nutrition and Cancer 19(2): 207-212

Kikugawa, K.; Hiramoto, K.; Tomiyama, S.; Asano, Y. 1997: Beta-Carotene effectively scavenges toxic nitrogen oxides: nitrogen dioxide and peroxynitrous acid. Febs Letters 404(2-3): 175-178

Carlos, T.F.; Riondel, J.; Mathieu, J.; Guiraud, P.; Mestries, J.C.; Favier, A. 1997: Beta-carotene enhances natural killer cell activity in athymic mice. In Vivo 11(1): 87-91

Coodley, G.O.; Nelson, H.D.; Loveless, M.O.; Folk, C. 1993: Beta-Carotene in HIV infection. Journal of Acquired Immune Deficiency Syndromes 6(3): 272-276

Coodley, G.O.; Coodley, M.K.; Lusk, R.; Green, T.R.; Bakke, A.C.; Wilson, D.; Wachenheim, D.; Sexton, G.; Salveson, C. 1996: Beta-carotene in HIV infection: an extended evaluation. Aids 10(9): 967-973

Canfield, L.M.; Giuliano, A.R.; Neilson, E.M.; Yap, H.H.; Graver, E.J.; Cui, H.A.; Blashill, B.M. 1997: Beta-Carotene in breast milk and serum is increased after a single beta-carotene dose. American Journal of Clinical Nutrition 66(1): 52-61

Kornhauser, A.; Wamer, W.G.; Lambert, L.A.; Wei, R.R. 1994: beta-Carotene inhibition of chemically induced toxicity in vivo and in vitro. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 32(2): 149-154

Sarkar, A.; Basak, R.; Bishayee, A.; Basak, J.; Chatterjee, M. 1997: Beta-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. British journal of cancer 76(7): 855-861

Phillips, R.W.; Kikendall, J.W.; Luk, G.D.; Willis, S.M.; Murphy, J.R.; Maydonovitch, C.; Bowen, P.E.; Stacewicz-Sapuntzakis, M.; Wong, R.K. 1993: Beta-Carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Research 53(16): 3723-3725

Johnson, E.J.; Qin, J.; Krinsky, N.I.; Russell, R.M. 1997: Beta-carotene isomers in human serum, breast milk and buccal mucosa cells after continuous oral doses of all-trans and 9-cis beta-carotene. Journal of Nutrition 127(10): 1993-1999

Palan, P.R.; Mikhail, M.S.; Basu, J.; Romney, S.L. 1992: Beta-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer. American Journal of Obstetrics and Gynecology 167(6): 1899-1903

Girard, P.F.lconnier, B.B.icout, J.V.adescu, B. 1994: Beta-Carotene producing mutants of Phaffia rhodozyma. Applied microbiology and biotechnology 41(2): 183-191

Yamaoka, Y.kiho; Takimura, Osamu; Fuse, Hiroyuki; Kamimura, Kazuo 1994: Beta-Carotene production by Dunaliella salina in fed-batch and semi-continuous cultures under nutrient supplement. Seibutsu-Kogaku Kaishi 72(2): 111-114

Yamoaka, Y.kiho; Takimura, Osamu; Fuse, Hiroyuki; Murakami, Katsuji; Kamimura, Kazuo; Ueda, Sadao; Saeki, Masamichi 1997: Beta-Carotene production by Dunaliella salina using boron-glass powder containing iron: Note. Seibutsu-Kogaku Kaishi 75(3): 181-184

Yamaoka, Y.kiho; Takimura, Osamu; Fuse, Hiroyuki; Kamimura, Kazuo; Murakami, Katsuji; Ueda, Sadao; Saiki, Masamichi 1996: Beta-Carotene production by Dunaliella salina using glass powder containing nutrients: Note. Seibutsu-Kogaku Kaishi 74(4): 269-272

Takeyama, H.; Sunarjo, J.; Yamada, A.; Matsumura, H.; Kusakabe, E.; Matsunaga, T. 1996: Beta-Carotene production in a novel hydrogen-producing marine photosynthetic bacterium Rhodovulum sulfidophilum expressing the Erythrobacter longus OCh101 crt I and crt Y genes. Journal of Marine Biotechnology 4(4): 224-229

Telfer, A.; Dhami, S.; Bishop, S.M.; Phillips, D.; Barber, J. 1994: Beta-Carotene quenches singlet oxygen formed by isolated photosystem II reaction centers. Biochemistry 33(48): 14469-14474

Von Laar, J.; Stahl, W.; Bolsen, K.; Goerz, G.; Sies, H. 1996: Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene. Journal of Photochemistry and Photobiology. B Biology 33(2): 157-162

Moriguchi, S.; Okishima, N.; Sumida, S.; Okamura, K.; Doi, T.; Kishino, Y. 1996: Beta-Carotene supplementation enhances lymphocyte proliferation with mitogens in human peripheral blood lymphocytes. Nutrition Research 16(2): 211-218

Meydani, M.; Martin, A.; Ribaya-Mercado, J.D.; Gong, J.; Blumberg, J.B.; Russell, R.M. 1994: Beta-carotene supplementation increases antioxidant capacity of plasma in older women. Journal of Nutrition 124(12): 2397-2403

Mobarhan, S.; Shiau, A.; Grande, A.; Kolli, S.; Stacewicz-Sapuntzakis, M.; Oldham, T.; Liao, Y.; Bowen, P.; Dyavanapalli, M.; Kazi, N. 1994: beta-Carotene supplementation results in an increased serum and colonic mucosal concentration of beta-carotene and a decrease in alpha-tocopherol concentration in patients with colonic neoplasia. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 3(6): 501-505

Traber, M.G.; Diamond, S.R.; Lane, J.C.; Brody, R.I.; Kayden, H.J. 1994: Beta-Carotene transport in human lipoproteins. Comparisons with a-tocopherol. Lipids 29(10): 665-669

Wamer, W.G.; Wei, R.R.; Matusik, J.E.; Kornhauser, A.; Dunkel, V.C. 1993: beta-Carotene uptake, metabolism, and distribution in BALB/c 3T3 cells. Nutrition and Cancer 19(1): 31-41

McLarty, J.W.; Holiday, D.B.; Girard, W.M.; Yanagihara, R.H.; Kummet, T.D.; Greenberg, S.D. 1995: Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. American Journal of Clinical Nutrition 62(6 Suppl): 1431s-1438s

Altiok, S.; Groner, B. 1994: Beta-Casein mRNA sequesters a single-stranded nucleic acid-binding protein which negatively regulates the beta-casein gene promoter. Molecular and Cellular Biology 14(9): 6004-6012

Matar, C.; Goulet, J. 1996: Beta-Casomorphin 4 from milk fermented by a mutant of Lactobacillus helveticus. International Dairy Journal 6(4): 383-397

Blass, E.M.; Blom, J. 1996: Beta-Casomorphin causes hypoalgesia in 10-day-old rats: evidence for central mediation. Pediatric Research 39(2): 199-203

Tao, Y.S.; Edwards, R.A.; Tubb, B.; Wang, S.; Bryan, J.; McCrea, P.D. 1996: beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex. Journal of Cell Biology 134(5): 1271-1281

Takayama, T.; Shiozaki, H.; Shibamoto, S.; Oka, H.; Kimura, Y.; Tamura, S.; Inoue, M.; Monden, T.; Ito, F.; Monden, M. 1996: Beta-catenin expression in human cancers. American Journal of Pathology 148(1): 39-46

Guger, K.A.; Gumbiner, B.M. 1995: beta-Catenin has Wnt-like activity and mimics the Nieuwkoop signaling center in Xenopus dorsal-ventral patterning. Developmental Biology 172(1): 115-125

Hoschuetzky, H.; Aberle, H.; Kemler, R. 1994: Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. Journal of Cell Biology 127(5): 1375-1380

Ilyas, M.; Tomlinson, I.P.; Rowan, A.; Pignatelli, M.; Bodmer, W.F. 1997: Beta-catenin mutations in cell lines established from human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 94(19): 10330-10334

Schneider, S.; Steinbeisser, H.; Warga, R.M.; Hausen, P. 1996: Beta-catenin translocation into nuclei demarcates the dorsalizing centers in frog and fish embryos. Mechanisms of Development 57(2): 191-198

Roep, B.O.; Kallan, A.A.; De Vries, R.R. 1992: Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes 41(11): 1380-1384

Homo-Delarche, F. 1997: Beta-cell behavior during the prediabetic stage. Part I. Beta-cell pathophysiology. Diabetes and Metabolism 23(3): 181-194

Shimada, A.; Charlton, B.; Taylor-Edwards, C.; Fathman, C.G. 1996: Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45(8): 1063-1067

Conget, I.; Sarri, Y.; Somoza, N.; Vives, M.; Novials, A.; Ariza, A.; Fernández-Alvarez, J.; Pujol-Borrell, R.; Gomis, R. 1997: Beta-cell function abnormalities in islets from an adult subject with nesidioblastosis and autoantibodies against the islet cells. Pancreas 14(1): 71-75

Bech, K.; Damsbo, P.; Eldrup, E.; Beck-Nielsen, H.; Røder, M.E.; Hartling, S.G.; Vølund, A.; Madsbad, S. 1996: beta-cell function and glucose and lipid oxidation in Graves' disease. Clinical Endocrinology 44(1): 59-66

Mehrotra, R.N.; Bhatia, E.; Choudhuri, G. 1997: Beta-cell function and insulin sensitivity in tropical calcific pancreatitis from north India. Metabolism, Clinical and Experimental 46(4): 441-444

Xu, G.; Tanigawa, K.; Nakamura, S.; Kawaguchi, M.; Kato, Y.; Tamura, K. 1995: Beta-cell function and replication in spontaneously hypertensive rats. Metabolism, Clinical and Experimental 44(10): 1360-1364

Beshyah, S.A.; Gelding, S.V.; Andres, C.; Johnston, D.G.; Gray, I.P. 1995: Beta-cell function in hypopituitary adults before and during growth hormone treatment. Clinical Science 89(3): 321-328

Arata, M.; Fabiano de Bruno, L.; Goncalvez Volpini, W.M.; Quintans, J.C.; D'Alessandro, V.G.; Braun, M.; Basabe, J.C. 1994: Beta-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 206(1): 76-82

Koyama, K.; Chen, G.; Wang, M.Y.; Lee, Y.; Shimabukuro, M.; Newgard, C.B.; Unger, R.H. 1997: Beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 46(8): 1276-1280